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Abstract 
African American women are 42% more likely to die from breast cancer than 
their White counterparts. The purpose of this phenomenological study was to understand 
the lived experience of African American, female, survivors of triple negative breast 
cancer (TNBC) to determine if any of the key tenets of the social determinants of health, 
particularly race and place/social conditions, influenced their screening through treatment 
decisions or care. Through the interpretive description approach, six interviews were 
conducted with survivors of TNBC who either worked or resided in one of eight Monroe 
County zip codes: 14605, 14606, 14608, 14609, 14611, 14613, 14619, and 14621. These 
zip codes, home to 63% of the regions African American population, were selected 
because they had the highest rates of poverty, the worst health outcomes, and the lowest 
life expectancy of any other zip code in the nine county Finger Lakes region. 
The findings of this study revealed that the women did not believe their screening 
through treatment options were influenced by their race or place/social conditions. The 
following themes were identified: (a) the strength and resilience of the survivors was 
expressed through their faith and positive attitudes; (b) the importance of physician / 
patient relationships, including the dissemination of information and patient invalidation; 
(c) the need for self-advocacy; and (d) the role of support groups.  
Recommendations for future studies include suggested actions for researchers, 
physicians and patients to include: using measures of protective factors in research 
studies; training medical professionals in areas of cultural humility, implicit bias, and 
structural racism; and, encouraging women to be vulnerable and accept help.  
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Chapter 1: Introduction 
The human body is made up of various types of cells that are distinct to certain 
parts of the body. Normal, healthy cells divide, grow, and die in a prescribed way 
(National Cancer Institute [NCI], 2016). However, in some instances, the normal growth 
and life cycle of a cell is disrupted and cells begin to grow or divide irregularly. In most 
cases, when cells develop in this way, an excess of tissue can form. This excess tissue is 
known as a tumor (NCI, 2016). 
A tumor is classified as benign or malignant based on whether or not cancer is 
present (NCI, 2016). A benign tumor is not cancerous and usually does not pose a threat 
to the life of the individual. Conversely, malignant tumors are cancerous and can grow 
out of control and metastasize to other parts of the body. While not all cancers appear as 
tumors, cancer can be fatal if the growth and spreading of the disease is not controlled. 
The term cancer is credited to the Greek physician Hippocrates (460-370 BC) 
who used the terms karkinos and karkinoma to describe the tumors finger-like spreading 
projections which, he thought, resembled the shape of a crab (American Cancer Society 
[ACS], 2016). Celsus (28-50 BC), a Roman physician, later translated the Greek term 
into the Latin word for crab, cancer (ACS, 2014). Cancer is now used as a generic term 
for a group of diseases that occur when cells begin to grow and spread abnormally (NCI, 
2016).  
There are more than 100 types of cancer and they can occur anywhere in the body 
(NCI, 2016). Cancers are classified by their histology (type of tissue in which the cancer 
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originates) or by their site (part of the body) of origination. There are five main 
histological categories of cancer: leukemias which are cancers of the blood and bone 
marrow; lymphomas, cancers of the lymphatic system, particularly the spleen, tonsils, 
and thymus; myelomas which originate in the plasma cells of the bone marrow; sarcomas 
which are cancers that begin in the supportive or connective tissues such as the bones, fat, 
tendons, cartilage or muscles; and carcinomas which begin in the skin or in the tissue that 
lines or covers body organs (NCI, 2016). More commonly, however, cancers tend to be 
described by the site of origin (NCI, 2016). Carcinomas, the most common histological 
category of cancer, include the most familiar sites for cancers to occur: colorectal, 
cervical, stomach, liver, lung, prostate, and breast cancers (NCI, 2016).  
Breast Cancer 
Not including skin cancers, breast cancer is the most common cancer found in 
women, and the second leading cause of cancer death for women in the US (ACS, 2016). 
It is estimated that 1 in 8 women will develop invasive breast cancer in her lifetime 
(ACS, 2016).  Approximately, 246,660 new cases of invasive breast cancer, alone, will 
be diagnosed in women, and close to 40,450 women will die from the disease annually, 
with the majority being African American (ACS, 2016).  Historically, African American 
women have had a lower incidence rate of breast cancer, but a higher mortality rate than 
White women (ACS 2016).   
Breast cancer history.  The world’s oldest recorded case of breast cancer dates 
back to 3000 BC and is documented in the Edwin Smith papyrus. The Edwin Smith 
papyrus, part of an ancient Egyptian textbook on trauma surgery, contained descriptions 
of incurable tumors in the mummies’ bones and breasts (ACS, 2016). It describes eight 
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cases of tumors of the breast in an Egyptian mummy (ACS, 2016). According to the 
inscriptions there was no treatment for the disease (ACS, 2016). It would take centuries 
before advances in science and increased public awareness would change opinions about: 
who could get the disease, how the disease should be treated, and the characteristics of 
the disease. 
Well into the mid-20th century, breast cancer was thought to be a disease of 
affluent, White women (Wailoo, 2010). While a few cases of Black women with breast 
cancer were known, the incidence of disease was reported overwhelmingly in White 
women of high socioeconomic status (Wailoo, 2010). It was not until the 1970s, when the 
famed singer, Minnie Riperton publicized her bout with the disease, that the public’s 
awareness about the effects of breast cancer on African American women was raised 
(Wailoo, 2010).  
In the three decades between 1975, when data first started being collected, and 
2006, when the incidence rate for White women was the lowest, Surveillance, 
Epidemiology and End Results (SEER) data, a national source for information on cancer 
incidence and survival in the United States (National Institutes of Health, 2016), showed 
the shift in incidence and mortality between Black and White women. During that time, 
Caucasian women had a 16% increase in breast cancer incidence and a 28% decrease in 
mortality rate, while African American women experienced a 29% increase in incidence 
and a 6% increase in mortality. After decades of misinformation, this data marked the 
awareness that not only did African American women get breast cancer, but that they 
were more likely to die from it, as well (Hunt, Whitman, & Hurlbert, 2013). This can be 
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seen below in Figures 1.1 and 1.2 retrieved from the National Cancer Institute’s SEER 
database.  
 
Figure 1.1. Age-adjusted Incidence Rates by Race/Ethnicity. Retrieved from the 
Surveillance, Epidemiology, and End Results (SEER) database of the National Institutes 
of Health. Available for public use. 
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Figure 1.2. Age-adjusted Mortality Rates by Race/Ethnicity. Retrieved from the 
Surveillance, Epidemiology, and End Results (SEER) database of the National Institutes 
of Health. Available for public use.  
Furthermore, for centuries, there was no standard of treatment for breast cancer 
and there was thought to be no cure (Lerner, 2001). Until the development of the radical 
mastectomy by Dr. William Stewart Halsted in the 1890s (ACS, 2014), attempts at 
treating breast cancer resulted in poor outcomes for the women. The radical mastectomy, 
 6 
which called for the complete removal of the breast, underarm lymph nodes and chest 
wall muscles, standardized the way breast cancer was treated. This disfiguring procedure 
remained common place until the 1970s when new research showed that less extensive 
surgery was effective for curing breast cancer in most women (Lerner, 2001).  
Also, around this time, other technological advances were being made for 
screening and treatment of breast cancer. White women were able to take advantage of 
mammography for the early detection of breast cancer, and the use of Tamoxifen as the 
systemic treatment therapy for breast cancer. Both of these advancements started to 
improve the health outcomes for White women while African American women did not 
reap these benefits (Hunt et al., 2012). Hunt et al. suggests that African American women 
could not take advantage of these advances in technology and treatment therapies because 
they were disproportionately poor and lacked access to resources and insurance that 
would allow them to afford the improved care. The researchers explain that medical 
advances contribute to disparities when the knowledge, technology, and effective medical 
interventions for controlling diseases exist, but are not easily accessible by all individuals 
due to social circumstances (Hunt et al., 2012).   
The third misperception centered on the characteristics of the disease. Until about 
a decade ago, breast cancer was thought to be one disease (Boyle, 2012). Only recently 
have multiple studies exposed breast cancer as a heterogeneous group of diseases that are 
distinguished by multiple histological and molecular characteristics (Gautam, Zhao, 
Band, & Band, 2010). Histological factors identify if the disease originated in the tissue, 
nodes, or ducts of the breast, and whether it is contained within the breast (in situ) or has 
spread (invasive) (Gautam et al., 2010). These distinctions allow the diseases to appear 
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differently, have varying risk factors, unique responses to treatment, and divergent 
outcomes (Weigelt, Geyer, & Reis-Filho, 2010). Additionally, malignant cells can invade 
the entire breast and spread to other parts of the body (ACS, 2015). 
Breast cancer subtypes. More recently, breast cancers have started to be 
categorized by their molecular characteristics (Irvin & Carey, 2008). The presence or 
absence of the estrogen (ER) or progesterone (PR) hormone receptors and the 
overexpression of the human epidermal growth factor receptor (HER2) determine the 
specific types of breast cancers (Irvin & Carey, 2008).  These molecular subtypes are 
categorized into distinct groups known as: luminal A and luminal B which tend toward 
being hormone receptor positive, basal type which tends toward being hormone receptor 
negative and includes the triple negative sub-type, and HER2 type which have an 
overexpression of the HER2 gene/protein (ACS, 2015). The various subtypes also 
determine the treatment options and prognosis for each disease (Irvin & Carey, 2008). 
As much as 70% of breast cancers are diagnosed as hormone receptor positive 
and fall under the luminal A and B subtypes (Irvin & Carey, 2008). The luminal subtypes 
tend to have better prognoses because these cancers grow slowly, are considered lower 
grade, and have multiple, available treatment options which make survival more likely 
(ACS, 2015). These breast cancers are more likely to be diagnosed in postmenopausal, 
Caucasian women of higher socioeconomic status (Adams et al., 2012). 
Approximately 15%-20% of breast cancers are diagnosed as triple negative. 
Triple negative breast cancers (TNBC) are absent the estrogen (ER) and progesterone 
(PR) hormone receptors and the normal expression of the HER2 gene/protein (Irvin & 
Carey, 2008). Unlike the luminal subtypes, these basal type cancers tend to grow more 
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aggressively and are resistant to current treatment options and hormonal therapies 
(Agurs-Collins, Dunn, Browne, Johnson, & Lubet, 2010). The lack of the ER and PR 
make this form of breast cancer more difficult to treat with conventional medicines (Irvin 
& Carey, 2008), leaving chemotherapy as the predominant form of treatment. TNBC are 
more likely to be diagnosed in premenopausal, African American women (Adams et al., 
2012). Table 1.1 outlines the characteristics of each breast cancer subtype and its 
prevalence in the population. 
Table 1.1 
Delineation of Breast Cancers by Subtype 
Subtype Tumor type Prevalence 
Luminal A ER-positive and/or PR-positive 
HER2-negative  
30-70% 
 
Luminal B ER positive and/or PR positive, 
HER2+ or HER2- 
10-20% 
Triple Negative 
(Basal-type) 
ER-negative 
PR-negative 
HER2-negative 
15-20% 
 
HER2 type 
 
ER-negative 
PR-negative 
HER2-positive 
5-15% 
 
 
Triple negative breast cancer (TNBC).  As previously explained, TNBC gets its 
name because it is void the estrogen and progesterone hormone receptors, and the 
overexpression of HER2/neu protein (Irvin & Carey, 2008). While anyone can get 
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TNBC, the Carolina Breast Cancer Study showed that premenopausal, African American 
women are two to three times more likely than Caucasian women to be diagnosed with 
this form of breast cancer (Sturtz, Melley, Mamula, Shriver, & Ellsworth, 2014). Data 
show that women, who carry the BRCA 1 gene mutation, are under age 40, or African 
American tend to have higher incidence rates (Irvin & Carey, 2008) of TNBC. Of the 
study group, TNBC comprised 39% of the tumors in premenopausal, African American 
women compared to 14% in postmenopausal African American women and 16% in non-
African American women of any age (Carey et al., 2006).  
As stated, TNBC tends to grow faster and metastasize quicker than other 
mutations of breast cancer (Irvin & Carey, 2008). The lack of hormone receptors makes 
this form of breast cancer resistant to current treatment options that target the ER and PR 
positive subtypes of breast cancer leaving chemotherapy and radiation as the predominant 
option for treatment (Irvin & Carey, 2008). Due to its aggressive nature, presence at ages 
younger than 40 which is the recommended age for women to start screening for breast 
cancer (NCCN, 2016), and lack of treatment options, women diagnosed with TNBC have 
a higher recurrence rate within the first 3 years after treatment and a poorer prognosis for 
survival (Irvin & Carey, 2008). Some researchers have suggested that the high mortality 
rates for African American women from breast cancer may be due to TNBC (DeSantis,  
et al., 2015).  
Breast cancer incidence. As demonstrated in Figures 1.1 and 1.2, African 
American women have a lower incidence rate of breast cancer (Amirikia, Mills, Bush, & 
Newman, 2010), but a higher mortality rate than White women (ACS 2016). However, a 
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noticeable change in incidence rate of breast cancer occurred between 2008 and 2012 for 
African American women (DeSantis et al. 2015).   
DeSantis et al. (2015) conducted a study on incidence rates of breast cancer 
among Black and White women. Data were collected on incidence trends, probabilities of 
developing cancer, and cause-specific survival information from the SEER database, 
which has been collecting clinical, pathological, and demographic information on patients 
since the early 1970s. Additionally, the National American Association Central Cancer 
Registries was used to obtain data on incidence rates by race and ethnicity, stage at 
diagnosis of breast cancer, and the distribution of breast cancer by sub-type, including the 
overexpression of HER2. DeSantis also looked at state level data for incidence rates, 
stage at diagnosis, and subtype of breast cancer. Analysis of these data by age, 
race/ethnicity, stage at diagnosis, and mortality trends revealed an increase in incidence 
rates of breast cancer for African American women while there was a decline in 
incidence for White women (DeSantis et al., 2015).  
Data pertaining to screening rates were available from 2008-2012 from all 50 
states for White women and from 34 states for African American women. Sixteen states 
were not included for African American women because they did not have large enough 
sample sizes. Screening rates ranged from 66% in Wyoming (lowest) to 89% in 
Massachusetts (highest) for White women age 45 and older, while screening rates for 
African American women ranged from 68% in Colorado (lowest) to 89% in Maryland 
(highest). The screening rates for both groups appear to range similarly, or slightly higher 
for African Americans (DeSantis et al., 2015).  
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During the same time period, the overall incidence for breast cancer ranged from 
107.7 cases in Arkansas to 164.4 cases in Washington D.C. for White women, and 94.0 
cases in Minnesota to 141.7 cases in Alaska for African American women (DeSantis et 
al., 2015). Of the 42 states and the District of Columbia, where the rate ratios for 
incidence were examined, the incidence rates of breast cancer were significantly higher 
for African American women than for White women in seven states (Alabama, Kentucky, 
Louisiana, Mississippi, Missouri, Oklahoma, and Tennessee).  In 11 states and the 
District of Columbia, the rates for African American women were lower than White 
women, and in 24 states there was no significant difference. Although African American 
women traditionally had lower incidence rates, in this study, the incidence rates were 
relatively equal.  While the increase in incidence rates could not be explained explicitly, 
DeSantis et al. noted that when there is an increase in screening rates, it is expected that 
there will be an increase in incidence rates because more women are undergoing 
mammograms to find cancer early. This argument can be supported as we see the ranges 
for screening rates between African American and White women are relatively similar.  
Consequently, the increase in incidence rates could translate into an even greater 
increase and disparity in mortality rates for African American women. While there has 
been a decrease in mortality rates for both races over time, the decline has been much 
slower for African American women (Hunt, Whitman, & Hurlbert, 2013). Mortality rates 
for both races were virtually equal until the mid-1980s (Figure 1.2) when the gap 
between these two populations began to widen. During that time, it is evidenced that the 
mortality rate for African American women started to increase while the mortality rate of 
Caucasian women decreased rapidly.   
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In a study of the largest U.S. cities, Hunt et al. (2013) examined the breast cancer 
mortality rates of women from 1990-2009. The researchers measured the disparity by 
calculating the African American: White rate ratio (RR) for each city at varying 5 year 
intervals: 1990–1994, 1995–1999, 2000–2004, and 2005–2009. The researchers noted 
that of the 41 cities included in the study, 35 cities had a significant increase in the 
mortality gap between African American and White women over the 20 year time period. 
For example, in Los Angeles between 1990 and 2009 the mortality rate for African 
American women increased from 45.1 to 45.6. Conversely, the rate decreased from 36.5 
to 26.7 for White women. So, while the African American rate increased marginally, the 
White rate decreased drastically by 27% (Hunt et al., 2013). Thus, the researchers 
showed that African American women bear much higher breast cancer mortality than 
White women (Hunt et al., 2013), and this gap may worsen in light of the increase in 
incidence rates for African American women. 
Race/African Ancestry 
In a study examining high risk breast cancer in a sub-Saharan African population 
(Newman, 2014), it was suggested that in the case of TNBC, women with African 
ancestry may have a biological predisposition to getting this form of breast cancer. 
Researchers have identified a pattern of molecular biomarkers in the mammary stem cells 
of sub-Saharan African populations that may be linked to African American women. In 
the US, roughly 20% of White women with breast cancer are diagnosed before age 50 
compared to 33% of African American women with breast cancer (Newman, 2014). 
Additionally, the BRCA 1 gene mutation is disproportionately found in African 
American women, and those women are more likely to be diagnosed at younger ages 
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(Newman, 2014). While socioeconomic factors may contribute to worse health outcomes, 
Newman argues that it does not account for the age specific patterns of breast cancer 
incidence seen in women with TNBC (2014).  
Other studies have also reported evidence that genetics may be a contributor of 
TNBC in African American women with breast cancer. One study of patients in Florida 
identified a BRCA1 gene mutation unique to African American women with 
Caribbean/African ancestry (Akbari, Donenberg, & Lunn, 2014). Another study of 148 
Nigerian women with breast cancer found that 67% of the women were under age 50 
with a mean age of 44 (Ikpatt et al., 2005). The Black Woman’s Health Study looked at 
genotyping and identified patterns in breast cancer that correlate with TNBC and are 
associated with African ancestry (Newman, 2014). The University of Michigan-Ghana 
partnership also identified new patterns of molecular markers which have shown to be 
increased in the breast specimens of sub-Saharan African populations (Newman, 2014).  
Although studies of genetics in cancer are limited, there is some evidence that 
African American women are predisposed to an aggressive form of breast cancer thus 
providing an explanation for the disparities in mortality rates. However, further research 
is needed to examine if there is a biological basis for the development and progression of 
TNBC in African American women, or if it is an outcome of social circumstances, 
policies or individual behaviors. 
 
 
Problem Statement 
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African Americans tend to have the shortest survival rates and highest mortality 
rates of any racial/ethnic group in the nation for most cancers (ACS, 2016). When all 
cancers are combined, the death rate for African Americans is 24% higher for men and 
14% higher for women, than their White counterparts (ACS, 2016). When delving deeper 
into the disparity that exists for certain cancers, it is even greater. Mortality rates from 
colorectal cancer are 52% higher in African American men and 41% higher in African 
American women than White men and women, respectively; the death rate for African 
American men from prostate cancer is 2.4 times higher than that of White men, and is the 
highest of any ethnic group; African American women are twice as likely as White 
women to die from cervical cancer; and African American women are 42% more likely to 
die from breast cancer than their White counterparts (ACS, 2016).  
It is evident, from the vast body of quantitative literature, that the reason for this 
health inequity is multifactorial. Researchers have cited a number of factors that include: 
technological advances (Hunt et al., 2013), biological predisposition to aggressive breast 
cancer subtypes (Agurs-Collins et al., 2010; Irvin & Carey, 2008; Newman, 2014), biased 
screening guidelines (Amirikia et al., 2010), lack of access to health care (Dai, 2010), and 
low socioeconomic status (Akinyemiju, Pisu, Waterbor, & Alkertuse, 2015) as driving 
forces for the disparity in breast cancer incidence and mortality. However, there is a gap 
in the literature because qualitative research that speaks to the African American 
woman’s experience and beliefs about the causes of incidence and mortality due to breast 
cancer has not been identified. While there is a plethora of theories that attempt to explain 
why Black women have higher mortality rates, qualitative research to understand the 
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lived experience of women who are survivors of this disease would enhance the field of 
study. 
Qualitative research would give voice to the survivors’ awareness of factors that 
may have impeded their care, and their beliefs about race and place as they relate to their 
experience with TNBC. While quantitative researchers have pointed to social 
circumstances and various aspects of life as the reasons that Black women have higher 
mortality rates, qualitative research to understand the lived experience of women who are 
survivors of this disease was scarce. 
Theoretical Rationale 
Improving the health outcomes for the poorest people has long been a goal of the 
World Health Organization (WHO). Dating back to the WHO’s 1948 Constitution, there 
was a push for collaboration between agriculture, education, housing, and social welfare 
sectors in order to achieve positive, health gains (WHO, 2010). In 1998, researchers 
contracted by the WHO identified the idea of using collective work to achieve better 
health outcomes as the social determinants of health (SDOH) (WHO, 2010). This 
concept, adopted in the field of public health, attempts to understand the multiple factors 
that affect a person’s health in order to improve health outcomes. WHO defines the 
SDOH as “the conditions in which people are born, grow, live, work, and age,” (2011). 
These determinants include: educational level, housing, employment status, family 
culture and traditions, community resources, physical environment, individual behaviors, 
access to health care, government policy, race, and others factors (Satcher, 2010). Hence, 
the conditions in which people live and/or work are a result of the social, economic, and 
political environment that helps shape their lives and is a manifestation of how money, 
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power, and resources are distributed in local communities. Reducing the impact of social 
and political conditions on health outcomes and mortality has been a public health 
priority for decades (Satcher, 2010).  
McGinnis and Foege (1993) reasoned that the true cause of death has more to do 
with lifestyle and social conditions, than to genetics and health care. They reviewed a 
compilation of articles published between 1977 and 1993, as well as, U.S. vital statistics 
and surveillance data that identified and quantified the major contributors to premature 
death in the United States. They weighed factors such as use of tobacco products, poor 
diet and exercise, and alcohol use, and concluded that about half of all deaths that 
occurred in 1990 could have been prevented. The researchers found that the 
preponderance of premature deaths were not linked to biology or to the medical system, 
but to the factors that influenced how people lived (1993). The measure of years of 
potential life loss (YPLL) was derived from this research (McGinnis and Foege, 1993) 
and links to the high mortality rates of certain populations. 
The social determinants of health framework is grounded in the understanding 
that a person’s health status is impacted by the social conditions in which they live, work, 
and play. While it has been long argued, and well documented, that SES and poverty 
contribute to poor health outcomes (Marmot et al., 1991), the quantified contribution of 
SES, as it relates to lifestyle choices, was identified in 1993 (McGinnis & Foege). 
Accordingly, it has been maintained that about one-third of all cancers could be 
prevented with lifestyle changes including reduction in obesity, better nutrition, and 
increased physical activity (ACS, 2016). Researchers have linked the SDOH to the high 
breast cancer mortality rates in African American women by explaining that policy 
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(Amirikia et al., 2010), poverty, and social conditions (Akinyemiju et al., 2015) impact a 
woman’s access to care, prior to, or in the early stages of the disease when it is most 
treatable. 
Statement of Purpose 
The purpose of this study was to understand the lived experience of African 
American women who survived triple negative breast cancer (TNBC). This study 
explored how these women experienced the key tenets of SDOH, specifically race and 
place, in regards to the quality of care they received during their cancer journey from 
screening through treatment. The focus was on survivors of TNBC who lived in 
neighborhoods with a high concentration of poverty, in the city of Rochester to 
understand if, and/or how, they believe race and/or place impacted their ability to access 
and receive quality health care. 
Research Questions 
Through qualitative methodology, the researcher explored how African American 
women experienced the key tenets of the SDOH, specifically race and place, as it related 
to their screening, diagnosis, and treatment for breast cancer. The interpretive descriptive 
research approach (Thorne, Reimer, Kirkham, & MacDonald-Emes, 1997) was utilized to 
give voice to the survivors’ awareness of the SDOH and their beliefs about race and 
place. The following questions guided the research:  
1. What are the African American women’s experiences with TNBC from 
screening through treatment?  
2. Do African American women believe race played a role in their screening 
through treatment options? 
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3. Do African American women believe that their place (social conditions in 
which they live or work) played a role in their screening through treatment 
options? 
Potential Significance of the Study 
Telling the stories of actual women behind the data will help to fill in the gaps left 
by the current quantitative research and add the substance of personal stories to data. 
Additionally, understanding the journey of African American women when coping with 
breast cancer may help health care professionals and community advocates understand 
how to better advocate for, and treat, this population of patients. Lastly, if women are 
able to recognize and identify social and institutional constructs that could have either 
impeded or facilitated their access to optimal breast cancer screenings and care, this could 
be a call to action for them to use their voice and power to work toward changing systems 
and practices that they deem harmful to their health and their communities. 
Definitions of Terms 
• Benign – tumors that are not cancerous 
• Caucasian/White - these terms are used interchangeably 
• African American/Black - these terms are used interchangeably 
• Incidence rate- the total number of new cancer cases diagnosed annually 
in the population of interest, divided by the at-risk population and 
multiplied by 100,000 (CDC, 2015) 
• Histology – type of tissue where the cancer originates 
• Malignant – tumors that are cancerous and could grow and spread  
• Metastasize - spread 
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• Mortality rate - the total number of cancer deaths annually in the 
population of interest, divided by the at-risk population and multiplied by 
100,000 (CDC, 2015) 
• Place – the social conditions in which a person lives or works  
• Poverty – not having enough money to meet daily needs. The amount is 
set by the Department of Health and Human Services. Federal poverty 
guidelines for 2017 is $12,060 for a single person (HHS.gov) 
• TNBC - Triple negative breast cancer that is void of the ER, PR hormone 
receptors, and overexpression of the HER-2 gene/protein (Irvin & Carey, 
2008) 
• Townsend Deprivation Index – census based index of material 
deprivations calculated by the combination of four census variables: 
unemployment, overcrowding, and not owning a car or a home (Messer et 
al., 2006) 
Chapter Summary 
More research is needed to understand the experiences of African American 
women and their ability to navigate their cancer screening, diagnosis, and treatment 
options. This study explored women’s social environment in an effort to determine 
whether or not they believed any of the tenets of SDOH played a role in their health care 
options. In so doing, the specific tenets of race and place were analyzed to understand 
what role, if any, the women believed they played.  
This dissertation is organized in five chapters. The Chapter 1 discusses the 
background related to the research topic. The Chapter 2 provides a selective review of 
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empirical studies relating to the research topic. In Chapter 3 illustrates the design of the 
research methodology and data collection process. Chapter 4 outlines the findings of the 
research study and Chapter 5 provides a discussion of the findings and outlines 
recommendations for future studies. 
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Chapter 2: Review of the Literature 
Introduction and Purpose 
There is an old African American adage that says “when White folks catch a cold, 
African American folks get pneumonia” (unknown). This saying seems to hold true when 
examining the health status of African American people living in the United States. It has 
been well evidenced in the literature that African Americans tend to fare worse than their 
White counterparts across various health indicators such as diabetes, cardiovascular heart 
disease, hypertension, and obesity (Mays, Cochran & Namdi, 2007). African Americans 
are 40% more likely to have high blood pressure, have a 77% higher rate of diagnosed 
diabetes, and have a shorter life expectancy than non-Hispanic Whites (Centers for 
Disease Control [CDC], 2015).  
These grim statistics also persist when discussing the burden of cancer endured by 
African Americans. As previously stated, African Americans have the highest mortality 
rate and shortest survival of any racial/ethnic group in the nation for most cancers 
(American Cancer Society [ACS], 2016). African American women are 42% more likely 
to die from breast cancer than their White counterparts (ACS, 2016).  
Researchers have attempted to explain this inequity by citing factors such as: 
technology, genetics, policy, lifestyle, and poverty as driving factors of disparities in 
breast cancer mortality. It is evident from the literature that the reason for the disparities 
in incidence and mortality rates is multifactorial. However, even with the plethora of 
reasons, gaps in the literature have been identified. 
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Chapter 2 describes the state of the science as it relates to the high incidence and 
mortality rates of African American women from TNBC. The review of the literature 
included the following themes: 
• the role of lifestyle and social factors on breast cancer incidence and survival 
rates  
• the impact of policies and guidelines on cancer incidence and mortality 
• racial differences that could account for differences in mortality 
• the comparison of breast cancer subtypes to TNBC and their impact on 
survival rates 
These four themes were explored to discuss the state of the science in this field. 
Lifestyle and Social Factors  
Socioeconomic status (SES). Numerous studies have sought to determine an 
association between breast cancer subtype, incidence rates, race, and SES (Adams et al., 
2012; Akinyemiju et al., 2015; Sineshaw et al., 2014; Vainshtein, 2008) in an effort to 
explain the high mortality rates for African American women. While studies have shown 
a correlation between White women with high SES and ER+ breast cancer, studies have 
not been as conclusive for African American women. Table 2.1 outlines the studies that 
were used to discuss this topic.  
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Table 2.1 
Articles Analyzing Socioeconomic Status and TNBC 
Author Year Results 
Vainshtein 
 
2008 African American women showed no significant 
difference in breast cancer incidence whether high SES 
or low SES 
Adams et al. 
 
2012 Regardless of insurance type, or stage of disease, the risk 
of excess death was 2.14 times higher for African 
American women than White women 
Sineshaw et al. 2014 The likelihood of being diagnosed with TNBC was 1.8 
times higher for African American women versus White 
women, regardless of SES status 
Akinyemiju et 
al. 
2015 Breast cancer incidence follows SES except in the case 
of African American women with TNBC, because 
TNBC is more prevalent in African Americans 
regardless of SES 
 
A meta-analysis of prior studies was conducted to see if SES could account for 
the difference in breast cancer incidence between races (Vainshtein, 2008). Using the 
PubMed database and multiple cancer registries, Vainshtein limited his findings to five 
studies between 1990 and 2006. All studies included in the meta-analysis compared  
differences in incidence rates for breast cancer at varying SES levels for women in four 
racial groups (White, African American, Asian, and Hispanic) or more. To compare SES 
across studies, Vainshtein calculated an incidence risk ratios (IRRs) for the highest SES 
and the lowest SES for each racial group (2008). IRR assessed SES using median 
household income, poverty rate, average education level, household crowding, 
employment rate and the Townsend deprivation index (Vainshtein, 2008).  
The findings showed that across four racial groups, White women had the highest 
incidence of breast cancer followed by African American women, Hispanic, and lastly, 
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Asian (Vainshtein, 2008). The findings also showed a significant difference in incidence 
between the highest and lowest SES levels. There was a positive correlation between high 
SES and breast cancer incidence in White, Hispanic, and Asian women (Vainshtein, 
2008). This disparity between race and high SES existed for White, Hispanic, and Asian 
women, but it did not appear for African Americans. African American women showed 
no significant difference in breast cancer incidence whether high SES or low SES 
(Vainshtein, 2008) suggesting that other factors may account for the racial disparity.  
While Vainshtein’s meta-analysis did not show a correlation between breast 
cancer incidence and SES for African American women, the findings could be skewed 
because the studies in the meta-analysis did not employ the same standards or definitions 
of SES. Vainshtein’s attempt at calculating an IRR to standardize the comparison was 
based on inconsistent factors in the individual studies. Hence, the following articles in 
this review consist of independent studies with standardized measures of assessment.  
A study of a multiethnic cohort of 1,209 women in South Carolina was conducted 
to understand the relationship between race and mortality rates of breast cancer patients 
(Adams et al., 2012).  Data used were only for women identified as African American or 
White with a confirmed diagnosis of breast cancer between 2000 and 2002. Researchers 
used data from one local hospital tumor registry system in South Carolina. Breast cancer 
types were identified as either, ER+/ER- or HER2+/HER2-. Stage of disease followed the 
American Joint Committee on Cancer (AJCC) criteria for patients and ranged from stage 
0 to stage V. The researchers controlled for some variables in SES, insurance status, and 
healthcare access by using a population receiving treatment at the same hospital with 
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standardized protocols for physician recommendations and treatment regimens (Adams et 
al., 2012).  
Adams et al. (2012) looked at survival rates at both 3-year and 5-year for breast 
cancer specific mortality, as well as death from any cause, to determine racial disparities. 
The study showed that African American women had significantly lower survival rates 
for both breast cancer and all-cause mortality. After controlling for age, insurance status, 
SES, and tumor stage, for breast cancer mortality specifically, researchers found that 
African American women had 2.41 times higher risk of death than White women. 
Researchers were unable to identify an association between mortality and SES, and 
suggested biological factors may be at the root of this disparity. Delineation by subtype 
was not conducted because this study took place prior to the identification of TNBC as a 
tumor type. Estrogen receptor status was categorized as positive or negative, and HER2 
status was classified as positive, negative, or borderline. PR was not used in this study. In 
later studies, TNBC is identified as a subtype to discern a correlation between SES, and 
race (Sineshaw et al., 2014). 
In a 2014 study, researchers wanted to determine the likelihood of being 
diagnosed with TNBC in minority populations versus Whites (Sineshaw et al., 2014). A 
sample of 260,144 breast cancer cases was identified from the National Cancer Database 
(NCDB), a national hospital-based cancer registry which collects data on approximately 
73% of US cancer cases (American College of Surgeons, 2016). Breast cancer cases in 
this sample were diagnosed between 2010 and 2011 (Sineshaw et al., 2014), the first two 
years that SEER uniformly collected data on tumor subtypes (NCI, 2016). Sineshaw et al. 
(2014) categorized the data into five age groups, six race/ethnic categories, and six 
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insurance status groups. SES was measured on insurance status and median household 
income as identified in the 2000 census. Stage of disease followed the AJCC criteria and 
ranged from stage I-IV and unknown, and tumors were classified into five subtypes: 
HR+/HER2−, HR+/HER2+, HR−/HER2+, HR−/HER2− (TN), and unknown (Sineshaw 
et al., 2014).    
Of the 260,174 cases, 11.7% were diagnosed as TNBC. Analysis of the TNBC 
cases showed that there were higher proportions of TNBC in women: under age 40, who 
were African American, of low SES, and with Medicaid insurance. After controlling for 
SES, the study showed the likelihood of being diagnosed with TNBC was 1.8 times 
higher for African American women than White women, regardless of SES status 
(Sineshaw et al., 2014). This study’s findings were similar to that of Vainshtein as no 
correlation was identified between SES and incidence rates for African American 
women. Like Adams et al., Sineshaw calls for more research into genetic factors. 
However, in a 2015 population-based study of 47,586 women, a correlation between SES 
and breast cancer incidence in African American women was identified (Akinyemiju et 
al., 2015).  
In 2015, researchers examined the association between SES, incidence rates, and 
breast cancer subtypes (Akinyemiju et al., 2015). While studies showed that a positive 
relationship existed between high SES and breast cancer incidence in White women 
(Vainshtein, 2008), new researchers wanted to know if that relationship existed within 
each subtype (Akinyemiju et al., 2015). Akinyemiju et al. examined data of 47,586 
women diagnosed with breast cancer in 2010. This data were obtained from the SEER 
database which now contained information by tumor subtype. Of the breast cancer 
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subtypes, African American women comprised 22% of the TNBC cases and 61% of 
HR+, while White women were 11% of TNBC and 76% of HR+.  Hispanics and Asian 
Pacific Islander were 13% and 14 % of TNBC cases, respectively. Twenty-five percent of 
women resided in the highest SES neighborhoods and 14% in the lowest. SES was based 
on the NCI SES census tract index which used measures of income, poverty, 
unemployment, occupational class, education, and home value. Comparisons were made 
by examining each racial/ethnic group, separately, from lowest to highest SES by tumor 
subtype.  
As in Vainshtein’s study, a significant, positive correlation between higher breast 
cancer incidence and increasing SES was seen for White women. Furthermore, the 
stratification by subtype showed this trend to be associated with HER2−/HR+ and 
HER2+/HR+ cancers (Akinyemiju et al., 2015). By stratifying by sub-type, an 
association between SES and breast cancer was also seen for African American women 
with HR+ tumors. However, there was no correlation between SES and incidence of 
TNBC for African American or White women (Akinyemiju et al., 2015). This finding led 
researchers to believe that the positive association between SES and breast cancer 
incidence is driven by the type of breast cancer tumor.  This study did not look at 
differences in mortality rates, however.  
As outlined, the 2008 meta-analysis demonstrated that SES did not correlate with 
incidence rate for African American women with breast cancer (Vainshtein, 2008). 
Adams et al. (2012) study could not identify an association between mortality rates and 
SES. The 2014 study (Sineshaw et al.) showed that African American women had a 
higher likelihood of being diagnosed with TNBC irrespective of SES. Finally, this 2015 
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(Akinyemiju et al.) study elucidated in its findings that breast cancer incidence does 
correlate with SES, except in the case of TNBC. Therefore, none of the studies were able 
to show a correlation between TNBC and SES.  
These studies highlight one of the inaccuracies that occur when treating breast 
cancer like a homogenous disease. HR+ breast cancers are the most common forms of 
breast cancer found in women accounting for at least 70% of all cases (Irvin & Carey, 
2008). This subtype is also more commonly found in post-menopausal, White women of 
higher SES. As cited above, the higher the SES, the more likely women are to get 
screened for breast cancer (DeSantis, 2015). Conversely, HR- breast cancers, like TNBC, 
are more likely to be diagnosed in premenopausal, African American women, in low SES 
conditions (Sineshaw et al., 2014), and only make up about 15% of cases. Since the 
number of TNBC cases is small in comparison to HR+ breast cancers, the disparity 
between race, breast cancer incidence, and SES is diminished when breast cancer is 
treated as a homogenous disease. More research should be done to understand why a 
correlation does not exist between SES and TNBC.  
 Obesity. Multiple studies have examined the relationship between TNBC and 
obesity (Cheng et al., 2015; Dawood et al., 2012; Mowad et al., 2013; Vona-Davis et al., 
2008) in an effort to explain the disparity in breast cancer mortality rates. According to 
researchers, obesity is a modifiable lifetime risk factor for postmenopausal breast cancer 
and it is associated with attributes of the neighborhood in which women live (Cheng et 
al., 2015). Low socioeconomic neighborhoods tend to have high volumes of retail food 
outlets, minimal parks, and recreational spaces, and limited businesses within one mile of 
neighborhood residences (Cheng et al., 2015). Women who live in low socioeconomic 
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neighborhoods, are more likely to be obese or overweight (Cheng et al., 2015). Hence, 
researchers are trying to understand if low socioeconomic status correlates with obesity, 
and low socioeconomic status correlates with most breast cancers, except TNBC, is there 
a correlation between obesity and breast cancer. Table 2.2 outlines the studies that were 
be used to explore this question. 
Table 2.2 
 Articles Analyzing Obesity and TNBC 
Author Year Results 
Vona-Davis 
 
2008 The expression of TNBC in Appalachian 
women was almost identical to that of African 
American women in the general population 
Dawood et al. 
 
2012 Women with TNBC had similar prognostic 
outcomes regardless of BMI classification. 
There was no significant difference in 
outcome across race. 
Mowad et al. 2013 Did not demonstrate an association between 
obesity, as measured by BMI, and the 
incidence of TNBC  
Cheng et al. 2015 Some association between obesity and 
mortality, but it differs across racial/ethnic 
groups. No association for African American 
 
To test the hypothesis of whether a relationship existed between TNBC and 
obesity, researchers looked to a population of Appalachian women with TNBC. 
Appalachia is a predominantly White, socioeconomically deprived, community in West 
Virginia with one of the highest obesity rates in the nation (Vona-Davis et al., 2008). In 
this retrospective study, researchers controlled for race by using a 95% White, female 
sample population (Vona-Davis et al., 2008). Researchers looked at 620 breast cancer 
patients who were treated in the Breast Care Clinic of the Mary Babb Randolph Cancer 
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Center between 1999 and 2004.  Of the breast cancer patients in the study, 117 were 
diagnosed with the TNBC subtype (Vona-Davis et al., 2008). Of these 117 women, 
38.9% were classified as obese and accounted for 49.6% of the women with TNBC 
tumors (Vona-Davis et al., 2008).  
The results of the study showed that the expression of TNBC in this community 
was almost identical to those of African American women in the general population. Of 
this sample, 44.5% of the TNBC cases appeared in premenopausal women younger than 
age 50; 20% were younger than age 40. As a result of this study, Vona-Davis et al. (2008) 
reasoned that the higher frequency of TNBC in African American women could be 
attributed to their lifestyle choices and the prevalence of obesity in that population. 
Hence, they concluded that the over-expression of TNBC is not a matter of race, but a 
matter of choices women make that result in them becoming obese. Since African 
American women in the general population are twice as likely to be obese than White 
women (American Psychological Association, 2013), this conclusion could have merit.  
In another study, investigating the prognostic outcomes of obesity on women with 
TNBC, specifically, Dawood et al. (2012) examined the relationship between the body 
mass index (BMI) of women with early stage TNBC and their survival outcomes. This 
retrospective study was conducted to determine if BMI impacted this cohort based on 
menopausal status and race. A total of 2,311 patients of the University of Texas M.D. 
Anderson Cancer Center with stage I-III TNBC diagnosed between 1990 and 2010 were 
identified (Dawood et al., 2012). BMI was calculated for this group and each person was 
classified as underweight (34.3%), overweight (30%) or obese (35.7%) (Dawood et al., 
2012). The findings showed that women with higher BMI tended to be postmenopausal, 
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African American, and at higher stage of diagnosis. However, the prognostic outcome 
was no different between the groups based on BMI or menopausal status. Hence, women 
with TNBC had similar prognostic outcomes regardless of BMI classification (Dawood et 
al., 2012). There was also no significant difference in outcome across race. 
Cheng et al. (2015) sought to answer the question of neighborhood attributes of 
healthy eating and physical activity, which according to SDOH, have an impact on an 
individual’s life expectancy. This study was designed to explore the specific 
characteristics of a neighborhood environment that related to obesity, as well as, 
determine the association of breast cancer mortality in relation to obesity across diverse 
racial/ethnic groups. This study was conducted using data from the California Breast 
Cancer Survivorship Consortium (CBCSC), a composition of six breast cancer studies of 
diverse racial/ethnic groups, and the California neighborhoods data system (Cheng et al. 
2015). A total of 8,995 women with breast cancer were identified, of which 47% were 
White, 20% Hispanic, 19% African American, and 14% Asian; 55% had HR- tumors; 
24% lived in low SES neighborhoods as determined by geocoding patient addresses and 
linking them to census and business data (Cheng et al., 2015). BMI was used to 
determine normal weight, overweight, and obesity.  
The study’s findings showed that some features of the neighborhood environment 
influenced rates of obesity and mortality following breast cancer diagnosis for Latinas 
and White women, but not for African American and Asian American women. There was 
a correlation between neighborhood features of low SES environments and the 
prevalence of obesity and mortality for women diagnosed with breast cancer. This 
correlation was most pronounced for White and Latina women, but was not evident for 
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African American women. While Cheng’s study was not TNBC specific, it did agree 
with the previous studies citing no demonstrated relationship between obesity, SES or 
mortality for African American women with breast cancer. 
Finally, Mowad et al. (2013) studied a small dataset of 183 women diagnosed 
with TNBC at the Feist-Weiller Cancer Center, the Louisiana State Health Science 
Center Shreveport or the E. A. Conway hospital in Monroe, Louisiana (Mowad et al., 
2013). Similar to Dawood et al., BMI was calculated and classified as normal or 
underweight, overweight or obese. African American women were more likely to be in 
the high BMI groups than White women (Mowad et al., 2013). To understand the 
relationship of BMI to health outcomes, the overall survival and the disease free survival 
rates were compared to the three BMI classifications (Mowad et al., 2013). The 5-year 
disease free survival rate was 63% for normal weight, 68% for overweight and 65% for 
obese. This study did not demonstrate an association between obesity and the incidence 
of TNBC as measured by BMI (Mowad et al., 2013). 
Of the four studies cited above, none of them were able to show an association 
between ethnicity, obesity, and TNBC. Similarly, there was no relationship evidenced 
between race, SES, and TNBC. More studies must be done to determine why TNBC acts 
differently than HR positive subtypes regarding its correlation to SES and obesity. 
Policies and Guidelines  
The WHO (2010) places the responsibility on local governments and policy 
makers to play a key role in implementing policies that will decrease health inequities. 
However, in the case of screening guidelines for breast cancer, the policies are 
inconsistent and confusing (ACOG, 2015). While the literature is scant on this topic, 
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screening recommendations from the American Cancer Society (ACS), the American 
Congress of Obstetricians and Gynecologists (ACOG), the United States Preventive 
Services Task Force (USPSTF), and the National Comprehensive Cancer Network 
(NCCN) have all been reviewed to discuss inconsistencies in recommendations. 
Screening mammography has proven to be the most effective method of detecting 
breast cancer early (Humphrey, Helfand, Chan, & Woolf, 2002). The earlier cancer can 
be found and treated, the more likely the chance of survival. As survival rates increase, 
mortality rates decrease, thereby reducing unnecessary deaths for women (Humphrey, et 
al., 2002). Regrettably, controversy exists regarding the age at which women should 
begin screening for breast cancer. Prior to 2009, the universally accepted 
recommendation was to start screening with annual mammography at age 40 (Amirikia et 
al., 2011). However, in 2009, the United States Preventive Services Task Force 
(USPSTF), a volunteer panel of national experts in prevention and evidence-based 
medicine, made its first recommendation to change the guidelines for routine screenings 
(USPSTF, 2009). 
 When the USPSTF changed its recommendation from annual mammograms 
beginning at age 40, to biennially starting at age 50 (USPSTF, 2009), the new guideline 
was met with controversy and criticism. Nonetheless, the USPSTF upheld its guideline in 
2015 with its updated recommendation (Siu, 2016). This issue was triggered by the 
landmark study which showed a 24% decrease in breast cancer related mortality between 
1989 and 2000 (Berry et al., 2005). The results of this study prompted the Cancer 
Intervention and Surveillance Modeling Network (CISNET) to conduct its own 
investigation to determine how mammography and adjuvant therapy contributed to the 
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significant reduction in breast cancer related mortality, the incidence of advanced breast 
cancer, and treatment-related morbidity (CISNET, 2006).  
The CISNET study reported on the number of women who would need to be 
screened, in each age group, in order to save one life (Amirikia et al., 2011). Based on 
CISNET’s calculations, approximately 1,900 women ages 40 to 49 years old would have 
to be screened in order to save one life compared to 1,300 women ages 50-59, or 400 
women ages 60 to 69 years old. The authors of the CISNET report stated that if the goal 
is to reduce mortality in the most efficient way, then screening biennially beginning at 
age 50 would be the best way to accomplish that goal. However, if the goal is to 
maximize life, then screening at age 40 would be the preferred strategy based on the 
benefits to screening ratio (Amirikia et al., 2011).  
In making its decision to recommend starting mammograms at age 50, the 
USPSTF considered the findings of the CISNET study and concluded that while 
mammography reduces breast cancer mortality, the least benefit is seen in women 
younger than age 50. Additionally, USPSTF cited that the psychological harm caused to 
women due to a false-positive (non-cancerous) or a false-negative (missed cancer) 
diagnosis could outweigh the potential benefit of screening (Siu, 2016). Therefore, it was 
determined that routine mammography would not be recommended for women ages 40-
49 who are at average risk for the disease. For women in that age group who are at 
increased risk due to the BRCA 1 or 2 gene mutations, family history, or personal history 
of chest radiation, it was suggested that these women weigh their options and decide with 
their physician when to undergo mammographic screenings (Siu, 2016).  
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This decision was a contentious issue for researchers and advocacy groups like 
the American Cancer Society (ACS, 2009). They argued that by excluding screening 
recommendations for women age 40-49, the chance of missing cancers would be 
increased. Although the likelihood of getting breast cancer increases with age, 21% of 
new cases and 12% of deaths occur in women under the age of 50, and close to 5% of all 
breast cancers diagnosed are found in women under age 40 (ACS, 2016). Furthermore, 
African American women under the age of 35 have breast cancer rates two times higher 
than that of White women, and are three times more likely to die from the disease (CDC, 
2015).  
Some researchers took particular interest in examining the new guidelines in an 
attempt to inform the USPSTF of the adverse consequence their recommendations would 
have on women, and particularly, on African American women (Amirikia et al., 2011). 
Amirikia et al. (2011) analyzed data for 278,241 women diagnosed with invasive breast 
cancer from the California Cancer Registry between 1988 and 2006. The researchers 
found that the average age of diagnosis for African American women was 7 years 
younger than that of White women (2011). Additionally, African American women were 
more likely to be diagnosed with breast cancer younger than age 45, and those cancers 
were generally diagnosed in later stages than their White counterparts (Amirikia et al., 
2011). Hence, increasing the screening age would disproportionately affect women who 
are prone to developing the disease in their younger years. Amirikia et al. (2011) 
contended that while the USPSTF was concerned with breast cancer mortality, their 
recommendation did not take the risk of disease to women age 40-49 into account.  
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Subsequently, the ACS, although it opposed the original USPSTF decision in 
2009, changed its own guidelines and increased its recommended screening age from age 
40 to 45 in 2015. Citing the same concerns as the USPSTF, the ACS stated that after 
careful examination of the burden of disease among women ages 40-54, it was 
determined that the risk of harm from false positive findings due to biopsies and 
unnecessary services, was greater than the risk of cancer in women ages 40-44 (ACS, 
2015). ACS determined that the balance of risk to reward becomes more favorable at age 
45. Both the USPSTF’s and ACS’ recommendations were silent on the disparity that 
could result due to this decision (Amirikia, et al., 2011). The National Comprehensive 
Cancer Network and American Congress of Obstetricians and Gynecologists (ACOG), 
however, continue to advocate for screening at age 40 (2015). ACOG stated that they 
interpreted the data and the weight assigned to the harms versus the benefits differently 
than ACS and USPSTF (2015).   
These changing and inconsistent guidelines could cause confusion for all women, 
regardless of race. Although the USPSTF and ACS encourage individualized, informed 
decision making about when to start screening, women typically may not know if they 
are at increased risk for breast cancer. The breast cancer screening guidelines are a 
substantive issue as it is an area of controversy that affects the lives of thousands of 
women each year (Gersten, 2010). The guidelines set the standards for what procedures 
would be covered by insurance companies, and at what rate (USPSTF, 2016). So, while 
not overtly stated, it should be noted that by not screening women at age 40, insurance 
companies save money as they do not have to cover that procedure. 
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It also sets the standard by which women think about their own health. This issue 
crosses both the social and economic spectrums in its planning, decision making, and 
implementation processes. Hence, setting guidelines based on longevity, which has the 
objective of decreasing the years of potential life lost and maximizing life, rather than 
efficiency, would be the preferred model, especially for African American women 
(Amirikia, et al., 2011). This change in guidelines supports the argument that disparities 
exist because of policies and circumstances that are outside the control of the individual. 
Table 2.3 outlines the articles used to discuss the issues raised by the screening guidelines 
and recommendations. 
Table 2.3 
Articles Analyzing Screening Guidelines 
 Organization Year Screening Guideline 
 Amirikia et al. 2009 African American women were more likely to be 
diagnosed with breast cancer younger than age 45, 
and that cancers were general diagnosed in later 
stages than their White counterparts 
 ACS 2015 Screening for Women at Average Risk beginning at 
age 45; Ages 40-44 should talk to their physician  
 NCCN 2015 Annual Mammograms Recommended for Women 
Beginning at Age 40 
 USPSTF 2016 Biennial Breast Cancer Screening Starting at age 50 
 ACOG 2011 Annual Mammograms Recommended for Women 
Beginning at Age 40 
 
Racism and Discrimination  
Anecdotal evidence of racism in the health care system has long existed. 
Fortunately, numerous studies have evidenced the association between perceived racism 
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and poor health outcomes (Griggs, Sorbero, Stark, Heininger, & Dick, 2003; Smedley, 
Stith, & Nelson, 2003; Taylor et al., 2007). The IOM report Unequal Treatment 
highlighted the extent to which people of color do not receive the same type of care as 
their White counterparts. Even when factors, such as insurance status and income, are 
controlled for, Black people tend to receive a lower quality of healthcare, including less 
access to specialty services and lower usage rates of high technology diagnostic and 
therapeutic procedures than White people, (Smedley et al., 2002).  
Using Jones’s (2000) theoretic framework for understanding racism, there are 
three levels of racism which are defined as: institutionalized racism, personally-mediated 
racism and internalized racism. Institutionalized racism focuses on systemic conditions 
such as access to health insurance and healthcare facilities; personally-mediated racism is 
defined as prejudice and discrimination toward someone of another race, and internalized 
racism is the acceptance by individuals of stigmatized races of negative messages about 
their abilities and intrinsic worth (Jones, 2000). Unequal Treatment documents how these 
issues of racism and discrimination lead to health disparities. Breast cancer is one of 
those diseases that has a positive association with perceived racism (Taylor et al. 2007).  
The Black Women’s Health Study, was an ongoing prospective cohort study 
conducted between 1997 and 2003 (Taylor et al., 2007).  It was designed to examine risk 
factors for major illnesses in African American women.  Study participants were asked to 
complete surveys about their experiences with discrimination in two categories, everyday 
discrimination (being treated as dishonest) and major discrimination (unfair treatment - 
job, housing, and police) (Taylor et al., 2007).  Of the 59,000 respondents to the survey, 
593 were identified as having been diagnosed with breast cancer. The researchers found 
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that women under age 50, who reported frequent everyday discrimination, were at higher 
risk for breast cancer than those who reported infrequent experiences. Consequently, as 
women experienced major discrimination in one or more areas, researchers showed that 
their risk for breast cancer increased. This study demonstrated the positive relationship 
between perceived experiences of racism and increased incidence of breast cancer among 
African American women younger than age 50 (Taylor et al., 2007). 
Furthermore, other studies have identified systematic differences in the 
administration of chemotherapy with lower doses being given to African American 
women compared to White women (Griggs et al., 2003). Through a multivariate 
regression model, 489 cases of breast cancer treated between 1985 and 1997, across 10 
treatment sites, in two geographical regions were reviewed. The administered doses and 
dose intensity were compared to standard regimens. The mean unadjusted dose 
proportion was lower for African Americans than it was for Whites. Seventy-two percent 
of the White women received a dose proportion of 0.80 or greater compared with only 
61% of the African American women (Griggs et al., 2003). 
Racism and discrimination toward African Americans has a long and distinct 
history in this country. Even with advances in socioeconomic status, access to care, and 
technology, the legacy and destructive nature of racism and discrimination is ever present 
(Jones, 2000). These studies underscore how racism plays a role in the disparate health 
outcomes of African American women with breast cancer. There is evidence that social 
and environmental events can have an effect at the individual’s cellular and genetic level 
(Gehlert et al., 2008). Gehlert et al. looked at the model of downward causation and 
posited that the isolation and depression that is caused by social deprivation in turn 
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causes changes in gene expression which ultimately result in the TNBC diagnosis. As 
emphasized in Unequal Treatment: “The sources of these disparities are complex, are 
rooted in historic and contemporary inequities, and involve many participants at several 
levels, including health systems, their administrative and bureaucratic processes, 
utilization managers, healthcare professionals, and patients” (Smedley et al., 2002, p.18). 
Description of Data and Databases 
This section describes the research methods and measures used in the literature 
reviewed above. The methods used for all studies referenced above were quantitative, 
retrospective studies using data from multiple local, state, and national databases. The 
existence of statewide cancer registries and national databases provides readily accessible 
data for comparison analysis. Table 2.4 outlines some of the databases and datasets used 
for each study. 
Researchers used a variety of databases.  Akinyemiju et al. (2015) and DeSantis et 
al. (2015) collected data through the Surveillance, Epidemiology and End Results 
(SEER) database which is a product of the National Cancer Institute. This database has 
been collecting information on cancer diagnosis since 1973. This makes it a go to source 
for any researcher doing retrospective studies as it allows researchers to analyze data over 
decades. This database can be examined by race for African Americans and Caucasians 
individually, as well as, all races combined going back to 1973. It also captures incidence 
trends, probabilities of developing cancer and specific causes related to survival rates.  
Additionally, researchers used data from the North American Association of 
Central Cancer Registries (NAACCR). Established in 1987, it develops and promotes 
uniform data standards for cancer registries (NAACCR, 2016). Researchers who used 
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this database sometimes chose to exclude certain states if they did not meet the rigorous 
criteria for this registry. DeSantis (2016) excluded Arkansas, Minnesota, and Nevada 
because they failed to meet the NAACCR for one year or more between the time period 
from 2008-2012. DeSantis also excluded 15 states that did not have complete information 
for HER2 status which was added in 2010. 
More recent studies that analyzed breast cancer subtypes used data from 2008-
2012 and restricted it to women diagnosed in 2010 or later. Prior to 2010, HER2 status 
was not required by cancer registries. Akinyemiju et al. (2015) used data from SEER for 
women who were diagnosed in 2010 only, and limited their data to 18 population-based 
datasets in certain regions. This data set accounted for 28% of the population. Their 
dataset identified 47,586 women with breast cancer diagnosed in 2010 of which 12% had 
TNBC. In addition, they used census tract data from the National Cancer Institute SES 
index which is a measure of SES based on income, poverty, unemployment, occupational 
class, education, and house value. 
Researchers used various models to measuring SES. Many used census tract data 
to get their measurements. Sineshaw et al. (2015) used a measure of SES derived from 
U.S. census tract data. Sineshaw et al. (2015) were able to categorize individuals based 
on insurance status grouping those with private insurance as high SES, those on Medicaid 
as low SES, those in the middle as moderate SES and others as unknown if insurance 
status data was unidentifiable. Unlike other researchers, Sineshaw et al. (2015) did not 
use SEER for their datasets. Instead they used data from the National Cancer Data Base 
(NCDB) which is jointly supported by the American Cancer Society and the American 
College of Surgeons. NCDB has been collecting data on ER and PR status since 2004 and 
 42 
added HER2 in 2010, similar to SEER. Sineshaw et al. (2015) used data for 2010 and 
2011 from NCDB in order to measure breast cancer subtypes over time.  
Conversely, researchers used the same measure to determine normal weight, 
overweight, and obesity. Each researcher defined BMI using the standard method of 
dividing an individual’s weight in kilograms (kg) by the square of the height in meters 
(m2). BMI less than 25kg/m2 was considered normal or underweight. BMI of 25kg/m2 -
29.9kg/m2 was overweight, and BMI greater than 30kg/m2 was obese (Cheng et al., 2015; 
Dawood et al., 2012; Mowad et al., 2013; Vona-Davis et al., 2008). Using this standard 
measure made it simple to compare data across studies.   
Amirikia et al. (2011) used the SEER database to collect data from the California 
Cancer Registry to perform her study of young women with TNBC in order to address 
the USPSTF cancer screening guidelines. They analyzed age-specific invasive breast 
cancer data from 1998-2006 to determine the distribution of TNBC across three 
racial/ethnic groups. Although TNBC was not required to be reported until 2010, 
researchers were able to capture that information prior to 2010 from local databases. 
Cancer registries capture most aspects of cancer diagnosis including survival rates, 
mortality rates, demographic information for the population, and features of the disease. 
As the science evolves, the registry evolves to include information pertinent to the 
successful tracking and evaluation of cancer distribution across the population. 
Identified Gaps  
The state of the science explaining the high mortality rates of African American 
women from breast cancer is multifactorial and complex. While researchers have tried to 
explain the various aspects that contribute to increased death, it is still inconclusive as to 
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what factors are most attributable to the cause. Differing aspects of the social 
determinants of health (race, policy, access to care, and SES) all play a role in the high 
mortality rates of African American women with TNBC. Table 2.7 outlines the various 
factors discussed throughout the literature and denotes whether the factor contributes to 
increased disparities to care and/or increased mortality. However, the extent to which 
each of these contributes to the mortality rate is undetermined.  
Table 2.4 
Contributing Factors to Disparities in Care and Increased Mortality  
Factors Contributes to 
disparities in care 
Contributes to 
increased mortality 
Access to care: 
limited access to screening or 
treatment services 
X  
X 
Screening guidelines: 
guidelines not accounting for the 
earlier age at which TNBC is 
present 
X X 
Health insurance type/status: 
Medicaid/Private Insurance/no 
insurance determines what type of 
facility and level of care 
X X 
Obesity: modifiable risk factor 
linked to higher prevalence of 
breast cancer, except for TNBC 
 X 
Genetics: predisposition for 
women of African ancestry  
 X 
Socioeconomic Status (SES): 
linked to higher prevalence of 
breast cancer, except for TNBC 
X X 
Breast cancer subtype (TNBC): 
aggressive form of breast cancer 
with limited treatment options 
 X 
 
 44 
SDOH posits that the social and physical environment in which people live is 
more important to determining health outcomes, than their genetics or health behaviors 
(CDC, 2014). However, a clear, causal link has not been made between SES and 
incidence of TNBC (Adams et al., 2012, Akinyemiju et al., 2015; Sineshaw et al., 2014; 
Vainshtein, 2008;). High breast cancer incidence tends to follow high SES. However, 
researchers have concluded that the TNBC subtype seems to be independent of SES, and 
is more prevalent in African American women regardless of SES. Yet, it does tend to be 
more common in women of low SES.  
Obesity is a modifiable lifestyle risk factor that may contribute to breast cancer. 
Nonetheless, the research is not conclusive about whether or not that risk factor is 
distributed equally across breast cancer subtypes. As evidenced in the studies above, no 
associated link between race, obesity, and TNBC incidence could be identified (Cheng et 
al., 2015; Dawood et al., 2012; Mowad et al., 2013). This anomaly is leading researchers 
to believe that there may be a racial or genetic marker that causes African American 
women to be more susceptible to TNBC. 
The lack of evidence to support SDOH as a cause of higher mortality, favors 
researchers who have been investigating a link between TNBC and African ancestry. 
Researchers have been trying to understand the role that genetics play in the prevalence 
of African American women with TNBC by comparing populations in sub-Saharan 
Africa and the U.S. (Newman, 2014). The evidence demonstrates that the prevalence of 
TNBC in African women is mirrored in African American women in the U.S. (Newman, 
2014). TNBC has proved itself to be an aggressive form of breast cancer, with limited 
treatment options and poor prognosis (Irvin & Carey, 2008). If the evidence proves that it 
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is inherent in women of African ancestry, then it could be argued that the mortality rates 
will remain high as the only treatment option currently available for TNBC is 
chemotherapy and radiation (Irvin & Carey, 2008). Although, it is not clear why the 
disparity only started to appear in the 1980s, more studies must be done to understand the 
link between ancestral genetics and increased risk for TNBC. Research in this field has 
been limited and more studies of African populations may uncover a more definitive link 
that could explain the historical gap, as well.   
While it is understood that TNBC is most commonly found in women younger 
than age 40, it is still critical to review the recommendations for screening guidelines. 
The absence of discussion by the USPSTF and ACS about the disparity that exists for 
African American women could have an adverse outcome on that population. While the 
research on screening guidelines is not fully supported because the disparity still existed 
prior to 2009 when the guidelines were lower, future studies should address 
recommendations for screening African American women who are more likely to be 
diagnosed with a more aggressive form of breast cancer at earlier ages.  As African 
Americans are only 12%-13% of the U.S. population, it is not likely that the disparity will 
be uncovered when examining breast cancer at the population level (Amirikia et al. 
2009). Current recommendations are based on population-based data. 
SDOH also takes into account the lack of access to quality, affordable, and 
effective health care as a contributor to poor health outcomes and higher mortality. This 
includes the lack of access to early detection and treatment of the disease once it is 
diagnosed. As noted, the disparities gap began to widen in the 1980s when the 
recommended screening age was lower for the general population. However, as 
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technology advanced, the mortality rate for White women began to decrease while the 
rate for African American women increased. Technological advances in screening, like 
mammography, and treatment, like Tamoxifen, were not readily available to African 
American women (Hunt et al., 2013). Still, technological advances in screening do not 
address why African American women have a higher incidence of the TNBC subtype. 
And, technological advances in treatment do not help women with TNBC because TNBC 
is not responsive to adjuvant therapies. Future studies should exam new therapies for 
TNBC and an association with improved mortality.  
Chapter Summary 
Determining the reason for breast cancer disparities has proven to be fertile 
ground for researchers. Numerous studies have been conducted to identify the underlying 
cause for these disparities. Continued research to understand what role the SDOH play in 
the high incidence and mortality rates for African American women is needed. Genetics, 
the predisposition to certain diseases due to biology, or other aspects of SDOH are all 
viable concepts that may uncover some answers as to why TNBC disproportionately 
affects African American women. 
In conducting this literature review, only quantitative studies were found. 
Qualitative studies exploring the lived experience of African American women with 
TNBC were not identified. While researchers have pointed to social circumstances and 
various aspects of life as the reason that African American women have higher mortality 
rates, the field would be enhanced by a study to understand the lived experience of 
women who are survivors of this disease. 
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Chapter 3: Research Design Methodology 
Introduction 
Thirty–two years after the Department of Health and Human Services’ release of 
the Report of the Secretary's Task Force on African American and Minority Health in 
1985, the nation is still grappling with the issue of racial health disparities. The report 
elucidated the prevalence and impact of health inequities suffered by African Americans 
and other ethnic groups compared to their White counterparts. Based on recent data of 
mortality rates of African American women with breast cancer, it is apparent that health 
inequities continue to exist (ACS, 2016). 
Research Context 
In 2008, cancer became the leading cause of death in Monroe County, NY across 
all racial/ethnic groups (Epidemiology of Cancer in Monroe County, 2012). Monroe 
County has one of the highest breast cancer screening rates with 84% of women ages 50 
and older reporting having a mammogram within the past 2 years (Monroe County DOH, 
2012; Behavioral Risk Factor Surveillance System, 2012). Unfortunately, Monroe 
County also has among the highest incidence rates of breast cancer across the state with 
an average of 660.6 cases and 104 deaths, annually (NYS Cancer Registry and Cancer 
Statistics [NYS CRCS], 2010-2014). When examining the data by race, the national 
pattern of higher mortality rates for African American women compared to White women 
can also be seen locally. African American women have a mortality rate of 22.9 
compared to White women at 19.1 per 100,000 (NYS CRCS, 2010-2014).  
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While it is not known why African American women die at higher rates, the 
various factors that could contribute to this disparity have been outlined in Chapters 1 and 
2. As previously stated, those factors include social determinants, such as breast cancer 
screening policy and guidelines (Amirikia et al., 2010), poverty and social conditions 
(Akinyemiju et al., 2015), and lifestyle choices  that impact a woman’s access to care, 
prior to, or in the early stages of the disease when it is most treatable. This has also been 
witnessed locally, and is highlighted in eight of the most economically disadvantaged zip 
codes in the city of Rochester (Finger Lakes Health Systems Agency [FLHSA], 2014): 
14605, 14606, 14608, 14609, 14611, 14613, 14619, and 14621.  
These eight zip codes share a unique set of conditions, including an 
overrepresentation of African American residents, disproportionate percentage of 
residents with a low educational level, high concentration of poverty, and low 
socioeconomic status (FLHSA, 2014). Approximately 63% of African Americans living 
in the nine county Finger Lakes region (Orleans, Genesee, Wyoming, Monroe, Wayne, 
Livingston, Ontario, Yates, and Seneca) reside in these eight zip codes (FLHSA, 2014). 
Additionally, in these zip codes: 54% of Monroe County’s convenience stores, that do 
not provide healthy food options like fresh fruits and vegetables, are located; 33% of 
African Americans live in poverty; one-third of African American adults have less than a 
high school diploma; and African Americans suffer from multiple, preventable chronic 
diseases and have a 300% higher premature death rate than their White counterparts 
(FLHSA, 2014). Finally, the mortality rate of women dying from breast cancer in these 
zip codes was 55.9 compared to 49.5 for the rest of the county (NYS Vital Statistics 
2013). 
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These eight zip codes are marred by the conditions that are outlined in the SDOH. 
These zip codes have been identified by the African American Health Coalition (AAHC) 
as target areas in need of immediate community and policy interventions (FLHSA, 2014) 
because of their high rates of health disparities and the low life expectancy. It is for these 
reasons that these zip codes in the city of Rochester served as the subject area for this 
research project. 
Research Approach 
Interpretive description, a phenomenological, qualitative research approach was 
used for this study. This research approach was not used to make sweeping 
generalizations about the population, or to make broad changes in public opinion, policy, 
or practice. It was utilized to give meaning to the cancer survivors’ experiences (Thorne, 
et al., 1997). 
 Interpretive description is an inductive analytical research approach that draws 
from the qualitative methodologies of grounded theory, ethnography, and 
phenomenology, but goes beyond those disciplinary confines and creates a new way of 
interpreting and translating clinical phenomena for applied implications (Thorne, Reimer 
Kirkham, O’Flynn-Magee, 2004). It respects the prescriptiveness of the traditional 
methodological designs but understands that excellence in qualitative research requires 
the researcher to engage with the subject and have the intellectual capacity for inductive 
reasoning while interviewing. While interpretive description has emerged from other 
approaches, it is well suited to meet the needs of applied health care fields because it 
seeks to understand the shared experience of the subjects, as well as, their individual 
differences (Thome, Kirkham, & O'Flynn-Magee, 2004).  
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Interpretive description is designed for smaller scale qualitative studies using 
interviews, observations, and documentation as its data collection methods. It is widely 
used in the field of health care by nurses (Thorne et al., 2004). Its purpose is to capture 
themes and patterns in clinical phenomena and translate them into a description that 
could inform clinical practice (Thorne et al., 2004). It is a pragmatic approach that 
requires a logical framework rather than conventional procedures.  It draws on qualitative 
principles that understand that: (a) reality is complex, contextual, constructed, and 
subjective; and (b) the researcher and subject are inseparable and interact to influence 
each other (Thorne et al., 2004). Therefore, it does not require the researcher to bracket 
preconceived notions as it assumes the researcher has theoretical knowledge that forms 
the basis for the research. It relies heavily on the researcher’s process of intellectual 
inquiry which gives room “to see patterns, follow intuitions, and retrace a line of logical 
reasoning among and between pieces of data” (Thorne et al., 2004). However, it 
encourages the researcher to be skeptical of the obvious emerging themes and code 
broadly rather than precisely so that the researcher can be open to the infinite number of 
ways the data conveys the essence of the phenomena.   
Interpretive description allows the researcher flexibility and creativity in their 
research design while maintaining coherence, accountability, and integrity within the 
research study (Thorne et al., 2004). Knowledge gleaned from each interview informed 
the next interview. Questions were added, revised or deleted according to the discoveries 
made from the research subjects’ stories.  
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Research Participants 
The sample was comprised of survivors of TNBC who live or work in 
neighborhoods in the city of Rochester with a high concentration of poverty, particularly 
the following zip codes: 14605, 14606, 14608, 14609, 14611, 14613, 14619, and 14621. 
Various sampling techniques were used to identify the target population. 
First, nonprobabilistic, purposeful sampling was used to identify TNBC survivors. 
Purposeful sampling is used in qualitative research as a means of identifying and 
selecting specific populations related to the phenomenon being studied (Palinkas et al., 
2015). Within this sampling methodology, both homogenous and snowballing techniques 
were used (Palinkas et al., 2015).  
In order to understand how African American women experienced their breast 
cancer journey in light of SDOH factors, participants represented a homogenous group of 
women who: (a) identified as African American, (b) survived a diagnosis of TNBC, and 
(c) lived or worked in one of the eight aforementioned zip codes. This sampling method 
allowed participants to be selected through organizations that offered support to breast 
cancer survivors. These support groups met monthly and discussed topics that ranged 
from new diagnosis to survivorship for African American women living with breast 
cancer.  
With permission from the executive director or group leader of these 
organizations, the researcher attended one of the support group meetings to introduce the 
study to the members. Email solicitations were also sent to distribution list alerting 
women to the study and asking that they self-identify if they were interested in 
participating. The email contained the main criterion for inclusion into the study which 
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was that the women must be African American survivors of TNBC. The researcher did 
not have access to the survivor database, nor the names of the women that received the 
email message until they responded affirmatively to the email solicitation.  
As women self-identified for the study, the researcher was given their names and 
contact information as women of interest. Each interested woman was contacted by 
phone to inform them about the study in detail. Any concerns were discussed at the time 
and all questions were answered during the phone conversation.  
Snowball sampling was also used to solicit referrals from women who knew other 
survivors of TNBC (Palinkas et al., 2015). Snowballing is a form of sampling that can 
enrich sampling clusters, and allow the researcher to access new participants and groups 
when other avenues have been exhausted (Noy, 2008). Breast cancer survivors tend to 
know other women who have been diagnosed with the disease and can serve as a referral 
base for identifying women who may not currently attend a support group. Once 
participants had been identified through the multiple recruitment strategies, they were 
consented and interviewed. 
Instruments Used in Data Collection 
The purpose of the data collection process for this study was to obtain rich, 
descriptive data from face-to-face interviews, observations, and field notes. The 
interpretive description design was used to describe the lived experience of the survivors 
as they recalled their breast cancer journey (Thorne et al., 2004). Conducting interviews 
was an essential means of gathering data about the phenomena and allowing the 
participant to share their perspective (Creswell, 2014). The interview process permitted 
the researcher to ask open-ended questions, and let the researcher collect detailed 
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information from the participants which aided in ascribing meaning to the phenomena 
(Creswell, 2014). Hence, interviews were the primary source of data collection for this 
study. 
 The participants were solicited for the study by outreach through breast cancer 
survivors’ networks and support groups, snowballing, and self-selection after hearing 
about the study by word of mouth. Upon expressing interest in participating in the study, 
the interview date was set via email or over the phone. Prior to starting each interview, 
the participants received all information about the study including, time commitment, 
eligibility criteria, voluntary consent, and the timeline for study completion. All interview 
questions, demographic sheets, and questionnaires were reviewed by a team of 
researchers, professionals, and survivors to ensure clarity and ease of understanding prior 
to beginning interviews with the participants. Participants were also given the opportunity 
to ask questions and share concerns. After written consent was obtained, the interview 
was conducted.  
The researcher conducted face-to-face interviews with individual TNBC survivors 
to understand their experiences. The initial interview with the participants took place in 
their homes, or a private location of the interviewees choosing. First phase interviews 
were took approximately 45 - 75 minutes. These interviews included a review of the 
study and consenting of the participants. Additionally, this interview was designed to 
garner the most data. All interviews were recorded with the permission of the 
interviewee, and transcribed by a professional transcriptionist. Notes were identified only 
by the participants’ pseudonym.  
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The researcher also captured notes and recorded observations about the 
participants’ appearance, expressions, and mannerisms, as well as, their homes or the 
location they chose for the interview. The researcher also captured thoughts, 
observations, and perceptions throughout the process (Creswell, 2014).  
During the initial interview, the researcher asked open-ended questions to get a 
sense of the participant’s breast cancer experience. The initial question to the interviewee 
asked about their experience. From the researcher’s prior knowledge, it was understood 
that this was a common question posed to survivors that they were accustomed to 
answering. The breast cancer survivors tended to respond well to this question and it 
yielded rich, thick data. Subsequent questions probed for clarity and detail around the 
initial screening and follow-up procedures, such as: what prompted the screening; how 
long did it take to get follow-up services; what were they told about their diagnosis; who 
supported them through the breast cancer process; and, what were their feelings 
throughout this journey. The interviewer also asked similar probing questions about 
treatment: how did they decide their course of treatment; how long did it take to get to 
treatment; and, what was their support network?  Finally, interviewees were asked if they 
thought their experience differed in any way from other women.  
Toward the end of the interview, the women were given a list of factors from the 
social determinants of health. They were asked if they believed any of the factors played 
a role in their experience, and if so, to circle the factor(s). The factors listed included: 
race, education, age, income status, health insurance status, socio-economic status, and 
language. The women were asked to discuss how any of these factors played a role. 
Discussion of these factors occurred during the interview process. Nonetheless by 
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providing the list, it allowed the participants to confirm their initial statements, rethink 
their answers, or reject the factors. 
Finally, using the Qualtrics database, the researcher used a pre-existing template 
to design a short demographic information sheet to gather data about the participants. 
Questions included: gender, age range, income level, job type, education level, 
marital/partner status, sexual preference, place of birth, racial identification, regional 
identification, family make-up, and insurance status. This form was used at the end of the 
interview. Six interviews were conducted for this study. The various data collecting 
methods gave the researcher multiple ways to validate the findings including member 
check so that the researcher could verify thoroughness and clarity of thoughts 
Procedures for Data Collection and Analysis 
Analysis of interpretive description research calls for a critical analysis of the 
current knowledge of the subject and a concurrent and iterative process during data 
collection and analysis (Thorne et al., 2004). The critical analysis of the subject is 
outlined in Chapter 4: Results. Interpretive description allows for the iterative, ongoing 
process of data analysis in order to guide the data collection process. The concurrent and 
iterative process of data collection and analysis began with the first interview and 
continued throughout the study. As data were gathered and audio recordings of each 
interview were reviewed, the data were continually analyzed in an effort to inform future 
interviews. Creswell and Maietta (2002) state that data analysis is a “zigzag” process 
where the researcher collects and analyzes data throughout the entirety of the study. 
Information garnered from each interview informed the questions asked during 
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subsequent interviews. This approach allowed for the direction of the study to evolve as 
new knowledge was ascertained (Thorne et al., 2004).  
 Data analysis began with a review of the research questions. Interpretive 
description reasons that the initial research questions may have been created on the basis 
of limited information (Thorne et al., 2004). Fortunately, this was not the case. The 
following 11 questions guided the interviews: 
1. Tell me about how your breast cancer was detected.  
2. What prompted the mammogram?  
3. Tell me about the follow-up process once the abnormality was identified.  
4. What were you told about your diagnosis?  
5. How did you decide your course of treatment? 
6. What was your overall level of satisfaction from screening through 
treatment? 
7. How were you feeling throughout this journey?  
8. Did you feel supported?  
9. How were you supported through this process?  
10. Do you think your experience differed in any way from other women? 
11. Do you feel that your race or income level made a difference in your care? 
Questions were added, edited, or adjusted as needed according to the ongoing data 
analysis from previous interviews.  
 Observations were also critical to the data analysis process. It gave the researcher 
the opportunity to witness data about the study as it pertained to information about social 
supports, community comfort, racial identity, and accessibility to care. Field notes were 
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used to capture the physical environment, neighborhood, and racial identification of the 
participants. Observational data was analyzed alongside the interview transcripts, and 
were reviewed in an iterative process to inform the study. 
 Data was organized by demographic information, observational field notes, and 
interview materials. Coding was used to frame the initial research construct. The process 
of coding allowed the researcher the ability to combine data for themes and ideas.  
However, interpretive description warns against the excessive use of codes “as the 
exhaustive effort this typically entails can detract from the mind’s inherent capacity to 
see patterns, follow intuitions, and retrace a line of logical reasoning among and between 
pieces of data,” (Thorne et al., 2004).  
 The researcher immersed herself in the data in order to generate new meanings 
and insights. Intellectual inquiry guided the researcher’s exploration into the breadth and 
meaning of the data by asking questions like: how does this fit?; why was this said?; and, 
what has been learned? The transcribed interviews were analyzed for thematic codes. 
Initial coding identified recurring terms, descriptions, and feelings described by the 
participants or observed by the researcher, and documented in the transcripts and field 
notes.  
The initial codes were analyzed across interviews to generate the second level of 
codes. Further analysis through focused coding organized and consolidated the 
recurrences into higher order conceptual themes (Creswell 2014). Higher order themes 
were identified and categorized according to the previously identified tenets of SDOH. 
Through this process key findings emerged regarding strength, the physician / patient 
relationship, self-advocacy, and support. These themes were ordered into a narrative that 
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conveyed the essence of the experiences. Quotes from the survivors were used to 
highlight the themes and illuminate the story that was developed as a product of this 
study. These themes are explored in Chapter 4. 
Interpretive description supports the long held qualitative methodological concept 
that it is the researcher’s responsibility to grasp the data, create the meaning, posit the 
relationships, and recontextualize the data into findings (Morse, 1994). Interpretive 
description does not rely on the particularities of the steps taken to conduct the research, 
but on the knowledge and rationale of the researcher to interpret the data. It recognizes 
that while the explicit guidelines used for conducting the research may provide 
suggestions for future researchers, the findings may not be duplicated because it is the 
researcher who determines what data are relevant and how they are portrayed (Thorne et 
al., 2004). 
Credibility 
How well the researcher articulated the findings is the essential element in 
determining credibility or “interpretive authority” (Thorne et al., 1997). Credibility was 
derived from the transparency in the analytical. To ensure credibility, a brief summary of 
each participant was drafted to confirm they were identified and characterized accurately. 
Member checks were conducted with participants as they reviewed the study findings and 
confirmed the interpretations. Conclusions were tested with participants, as well. 
Triangulation was used to improve the credibility of the findings and 
interpretations. Method triangulation was reached through the use of multiple data 
collection methods including interviews, demographic information, notes, and 
observations (Polit & Beck, 2012). Themes were also cross-referenced with existing data 
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and studies. Findings were reviewed with experts in cancer research and public health 
who have knowledge of the subject. Comprehensive discussions were conducted to 
analyze the data based on what the experts already believed about the topic and what new 
knowledge was gleaned from the research.  
Data Storage and Security 
 Data was collected and stored digitally on a laptop which was attached to a server 
with login and logout requirements. The laptop was password protected and could not be 
lawfully accessed without the owner’s knowledge. As previously stated, all interview 
transcriptions were de-identified to maintain confidentiality of data and assigned code 
names represented by gem stones known only to the researcher. Transcripts were loaded, 
stored and analyzed in an Excel spreadsheet. Only participant pseudonyms appeared on 
data collection materials. All field notes were retained by the researcher and stored 
securely in a locked drawer when not in use. Audiotapes and research documents will be 
destroyed in compliance with IRB guidelines. 
Summary 
The lack of qualitative research about African American women with TNBC 
necessitated the use of the interpretive description research design. Interpretive 
description is a design that enables people, with similar experiences, to give voice to their 
stories in a holistic way while respecting the individuality of each person (Thorne, Con, 
McGuinness, McPherson, & Harris, 2016). Interpretive description demonstrates the 
importance of the lived experience and allows the exploration of new concepts so that 
they can be better understood (Thorne et al., 2016). By interviewing TNBC survivors in 
these neighborhoods, the researcher was able to give meaning to their experiences and 
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describe the role poverty and race played in their ability to access affordable, quality 
healthcare. 
Conducting research in this way is a valuable addition to the field as it informs 
clinical practice and future research by elucidating the social determinants of health 
through the perspective of the women who experience its tenets most closely. 
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Chapter 4: Results 
Introduction 
The purpose of this study was to understand the lived experience of African 
American female survivors of triple negative breast cancer (TNBC) to determine if any of 
the key tenets of the social determinants of health influenced their screening through 
treatment decisions or care. This study explored the women’s beliefs on factors 
including: race, socioeconomic status, age, education level or health insurance status 
affecting their ability to access and/or receive quality healthcare during screening, 
diagnosis and/or treatment.  
Using the interpretive descriptive qualitative research design, this study gives 
voice to the survivors’ experiences throughout breast cancer journey and offers insights 
into their state-of-mind, decision making process and recommendations for improved 
care. The following questions guided the research: 
1. What are the African American women’s experiences with triple negative 
breast cancer from screening through treatment? 
2. Do African American women believe race played a role in their screening and 
treatment options? 
3. Do African American women believe social conditions played a role in their 
screening and treatment options?  
This chapter presents the results of six interviews that were conducted from 
February 2017 to May 2017. It provides a brief description of each research participant to 
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allow the reader to know each woman individually. It outlines the methods used to collect 
and analyze the data including demographics, data collection procedure, and data analysis 
process. It is organized by major theme and excerpts from the interviews were used to 
highlight the participants’ experience. 
Participant Demographics and Description  
Demographic information for each participant was collected using a questionnaire 
that included birth year, gender, race/ethnicity, income status, zip code, marital status, 
employment status, and household size. Participants’ age at diagnosis ranged from 43-72 
years old. Education levels ranged from high school diploma to masters level degree. 
Participants were either currently employed or retired, and earned incomes ranging from 
$10,000 to more than $100K annually. Participants’ marital status varied across 
categories of married, separated, divorced or widowed. All participants were cisgender 
females of African descent identifying as Black, African American or Caribbean 
American. Two participants lived alone while the others lived with family members. All 
participants spoke English, and English was their primary language. Below is a chart of 
the demographic information. 
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Table 4.1 
Demographic characteristics 
Name 
(Pseudonym) 
Age Income Marital Education Racial 
Preference 
Employment  Zip 
Code 
Topaz 50s $100K+ Married Bachelors African 
American 
Full-time 14611 
Amethyst 40s $60K+ Separated Masters African 
American 
Full-time 14608  
Emerald 70s $60K+ Divorced Associates Black Retired 14619 
Diamond 70s >$20K Widowed High 
School 
Caribbean 
American 
Retired 14621 
Ruby Private Private Private Private Private Private Private 
Citrine 70s $40K+ Divorced Bachelors Caribbean 
American 
Retired 14608 
 
Six participants were interviewed for this study. They were selected through 
support groups, snowballing, and word of mouth. All participants consented to one-to-
one interviews which lasted between 45 and 90 minutes. All participants had completed 
treatment for TNBC prior to the interview, although two were still recovering from 
surgery or chemotherapy. All of the women lived or worked in one of the eight identified 
zip codes: 14605, 14606, 14608, 14609, 14611, 14613, 14619, and 14621. None of the 
women were visually overweight or obese. A few of them commented on the importance 
of living healthy lifestyles and being physically active. Their homes were well-kept and 
decorated with pictures, heirlooms, and items of cultural or familial pride. Participants 
were given pseudonyms represented by gemstones to maintain their confidentiality.  
Topaz. I met Topaz one evening after work at a local restaurant near her home. 
We sat in a corner booth far removed from the other patrons. Topaz is a mild-mannered, 
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soft spoken woman who appeared ready to share her experience with me. She was open 
about her journey and answered all questions in detail without hesitation. Topaz did not 
need much prompting as she recounted her story. Throughout our conversation, Topaz 
expressed how this experience gave her peace and perspective. “I must admit going 
through that whole process I really developed peace and I learned how to sit and be still 
for a while.” (Topaz, p. 3)  She shared that prior to her first diagnosis she was short-
tempered and impatient. However, during our time together, I saw nothing but a positive, 
inspirational woman who was hopeful that her experience could help others. 
Topaz lives and works in two of the eight identified zip codes in the City of 
Rochester. She has had two bouts with TNBC. She was first diagnosed in her late 40s and 
then again 5 years later in her early 50s. Topaz found both of her breast cancers as they 
were not immediately identified through the mammogram. In fact, three tumors were 
identified in the same breast over the 5-year period. Topaz spoke passionately about how 
her life changed through this process, and the importance of women living healthy 
lifestyles as a means to prevent cancer. She encourages all women to monitor their eating 
habits and remain physically active in order to maintain a healthy weight and reduce their 
risk for breast cancer.  
Amethyst. Amethyst lives in an identified zip code in Rochester. I met her at her 
home shortly after she had been discharged from the hospital for an emergency 
mastectomy. She was seated in her comfy chair with a machine, known as a Wound 
VAC, connected to her breast area working to close an open wound from the surgery. I 
did not discover this information until partway through the conversation. Her mother was 
also present as she had arrived from out of town to take of her. They seemed to have a 
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close relationship as her mom prepared lunch while Amethyst and I sat in the living room 
talking. Her mother intentionally stayed out of the way; however, I could see she was a 
caring and attentive woman as she even reminded me to put quarters in the parking meter 
to avoid getting a ticket.  
Amethyst was diagnosed in September 2016. She is the youngest participant of 
this study being diagnosed in her early 40s. She found her own breast cancer when she 
felt a lump in her breast. However, she delayed getting it diagnosed as she convinced 
herself it was something else. This was Amethyst’s only diagnosis of breast cancer, but 
her second bout with cancer as she had Hodgkin's lymphoma as a teenager. After having 
gone through chemotherapy in her childhood, Amethyst was adamant about not doing 
chemotherapy again. Hence her procrastination in getting her breast cancer diagnosed 
because, “I was in no rush to get a diagnosis and have doctors cramming that 
recommendation down my throat” (p. 2) 
As a substitute for chemotherapy, Amethyst researched other methods of healing 
and decided to use alternative therapies to beat this cancer. Amethyst, a knowledgeable 
and decisive woman, uses an array of herbs and supplements to manage her condition. 
She is also conscious of what she eats and understands how different foods may affect 
cancer’s growth or spread. Amethyst’s strength and determination led her to learn all she 
could about this disease and various complementary and alternative options for treatment. 
Amethyst would like women to know that they do not have to be beholden to traditional 
medicine and that there are other choices available.  
Emerald. I met Emerald in her home on a Friday afternoon. She, and her 
granddaughter, greeted me at the front door. We sat in the dining room and talked about 
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her diagnosis, as well as, the experiences that made her the strong woman she is today. 
Emerald is a retired engineer in her early 70s. She is the oldest of eight children, and 
grew up quickly as she had to raise her seven siblings in her mother’s absence. She 
continues to be a caregiver now taking care of her granddaughter who lives with her. 
Emerald has overcome many challenges throughout her life and credits many women in 
her past for molding her into a confident, resilient woman. “I stood on a lot of women’s 
shoulders. A lot of them” (p. 30). 
Emerald had no personal or familial history of cancer. She was diagnosed with 
breast cancer in 2012 in her late 60s after a suspicious spot appeared on her mammogram. 
However, because she had dense breast tissue, it took some time before the radiologist 
made a definitive diagnosis. Once she was diagnosed, Emerald chose to face her cancer 
journey primarily on her own. As she is the consummate caregiver and a fiercely 
independent woman, she chose not to involve anyone else and go it alone. Emerald is 
now a member of a local support group and chooses to share her story, strength and 
knowledge with newly diagnosed women to help them maintain their dignity and 
autonomy throughout their journey. She raises money to support breast cancer programs 
and mentors women who are new to the group. Emerald lives in an identified zip code in 
Rochester, and wants to share her story so that other women can be empowered through 
their experience, just like she was.  
Diamond. I met Diamond at her home on a Sunday afternoon. She is a retired 
woman who lives with her daughter and grandchildren in one of the identified zip codes. 
She spends most of the year in Rochester helping her daughter raise her grandchildren, 
but departs for a warmer climate a few months out of the year. We talked in Diamond’s 
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bedroom for privacy. Diamond is a pleasant and kind woman with a calming presence. 
She was diagnosed in October 2016 in her early 70s after her routine annual 
mammogram. She was still recovering from the side effects of chemotherapy at the time 
of our interview. Diamond’s positive attitude, quiet strength, and family support were 
essential to her recovery. 
Diamond relied heavily on the love and support of her daughter, extended family, 
and close friends to get through this experience. “My daughter would go with me every 
day for chemo and every day for radiation. My family would call. They would visit, 
which was a great success for me because I was able to recover quite nicely” (p. 3). Her 
daughter, who was Diamond’s primary caregiver throughout her journey, was also part of 
the interview. Diamond’s daughter accompanied her to all of her appointments, did 
research about TNBC, posed questions to the physicians, advocated for her when needed, 
and did everything she could to make sure Diamond made it through this experience in 
best possible way.  “Okay, focus on what's to be done. What's next? What do I need to 
do? What does she need to do to get to a place where she is whole again?” (p. 14). 
Diamond hopes to share a few words of wisdom for other women who have to face this 
disease.  
Ruby. I met Ruby after work on a Thursday evening in the conference room of a 
local organization. She is a very private woman and was hesitant to take part in the 
interviews. However, after hearing more about the study, she decided to participate. Ruby 
works in one of the identified zip codes. She lives with her husband and son in a suburb 
of Rochester. Although she didn’t say, based on our conversation, I estimate that Ruby is 
in her late 40s. She is an articulate, composed, and professional woman. She was the 
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most reserved of the women and was measured in her words not wanting to give too 
much away. What Ruby thought was going to be a quick conversation ended up lasting 
over an hour. 
We met at this particular place because it was a familiar and comfortable space 
for her as she has been a member of this organization since 2006 when she was first 
diagnosed with breast cancer. At that time, Ruby was in her early 30s. She had two more 
recurrences of breast cancer since then with the last one occurring in 2016. Each of 
Ruby’s experiences was different. She had three separate cancers occurring between both 
of her breasts. Each cancer’s identification, screening, and treatment were different. Her 
last diagnosis was confirmed as TNBC. It is unclear whether or not the first two 
diagnoses were TNBC as TNBC was not part of the lexicon at that time. However, Ruby 
does know that they were both estrogen receptor negative.  
Through her three experiences Ruby has amassed a wealth of information and 
knowledge. She wants women to understand the importance of research and self-
advocacy. Had she not advocated for herself during one of her experiences, she could 
have taken medication that had the potential to do her harm. Ruby wants women to glean 
whatever they can from her story so that they can have an experience with less fear, 
confusion and ambiguity. “I just heard the word to self-advocate. You really do have to 
mentor women not to just be the sick, poor person because, unfortunately, they [doctors] 
miss things, and it's too rushed. The system is too rushed. There's too much going on” (p. 
21). 
Citrine. I met Citrine in her home on a Thursday night. She is an independent 
woman who lives alone in one of the identified zip codes.  She is a retired woman in her 
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mid-70s. Like Diamond, she spends most of her time here but returns to her home 
country during the winter months. We sat in her dining room and talked for 
approximately 40 minutes. Citrine is a spiritual woman who gets her strength from her 
deep faith in the Lord. It was her faith that allowed her to maintain a positive attitude 
throughout her journey, and did not let the cancer diagnosis depress her or distract her 
from her regular routine. “Yeah, I went to [my country] as usual, and do what I had to do, 
as usual.” 
Citrine was diagnosed in 2011 during her routine mammogram. She was in her 
late 60s at the time. As she recounted her story, her strong faith came through in every 
word. She was resolute in her belief that the Lord would be her support and healer. 
Because she knew the Lord was the healer, she relied on his grace and mercy to see her 
through. She attended her appointments and her treatments without family and friends, 
but with the Lord by her side. The physician asked "Is anybody with you?" And I first 
said no. Then I said "Oh yeah! Yeah, somebody is with me." And he looked at me. I said 
"Yeah, Jesus is with me" (p. 5). Citrine opted not to do chemotherapy. She had surgery 
and radiation. Citrine is a 6 year survivor of her cancer. 
Each woman’s journey was different, but they had some characteristics that were 
the same: strength, faith, and self-advocacy. These characteristics are discussed further in 
the thematic findings. 
Thematic Findings 
 The purpose of this study was to understand the experience of women with 
TNBC to see if any of the key tenets of the social determinants of health influenced their 
screening through treatment decisions or care. At the end of each interview, the women 
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were asked if they felt race, educational level, age, income status, health insurance status, 
socio-economic status or language played a role in their screening through treatment 
options or in their level of care. While each participants’ experience was unique, many 
similarities emerged. Those similarities were categorized into themes with the key themes 
highlighted below. 
Policy and guidelines. Screening guidelines have been noted as a barrier for 
women because they can be confusing. Until 2009, the screening age for breast cancer 
started at age 40. However, with the recent changes to the guidelines, various 
organizations have established different guidelines ranging from age 40 to age 50 with 
intervals of 1 to 2 years. Yet, confusion of the guidelines was not an issue for these 
women. “But every year I went for my mammogram from the time I was 40. So it wasn't 
that I never went or I missed every year. I never missed on a mammogram.” (Citrine, p. 
9). However, starting in 2009 when the USPSTF changed the screening guidelines, 
various organizations have published different recommendations for when women should 
start getting screened.  However, none of these women cited screening guidelines as a 
barrier. “Through my primary care. He said I should start getting my mammogram every 
year. Every year in October, I would go and get screened” (Diamond, p. 8). They were all 
aware of the screening guidelines and when screening was appropriate for them. “I've 
been getting mammograms since my 30s because I had cancer when I was a kid” 
(Amethyst, p. 29). Even in the event when someone did not get screened, it was due to 
their own priorities and not any social circumstances. "It's sad to say that I've been too 
busy to have a mammogram" (Ruby, p. 13).  
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This suggests that women in Rochester, regardless of where they live, are aware 
of the importance of annual screenings. This also aligns with data that show Monroe 
County has one of the highest breast cancer screening rates in the state with more than 
80% of eligible women reporting that they received a mammogram at least once every 
two years (MCDOH, 2012). 
National breast cancer campaigns such as Susan G. Komen for the Cure, the 
American Cancer Society’s Making Strides in Breast Cancer Walk, and October Breast 
Cancer Awareness Month activities have helped to raise the level of consciousness and 
education about breast cancer. New legislation, like the Affordable Care Act and New 
York State’s Get Screened. No Excuses. campaign, makes it easier for women to get 
screened for breast cancer by removing cost sharing, mandating hospitals to provide 
screenings outside of the normal 9-5 business hours, and ensuring that breast cancer 
screening and diagnostic imaging services are paid in full by insurance. However, large 
disparities continue to exist in the health care system and trend across other chronic 
diseases and cancer types as outlined in Chapter 1. Fortunately, in the case of breast 
cancer, Monroe County has done better than most. However, this may be an exception, 
not the rule. 
TNBC. All of the research participants were survivors of TNBC. However, since 
TNBC is a fairly new discovery, it was not surprising to learn that the women were not 
familiar with this form of breast cancer. As Topaz stated: 
We both met with him and he described the type of cancer that I had. He said that 
it was a triple negative and that it was fast growing, very aggressive so they 
needed to start taking action immediately. I didn't really understand when he first 
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told me a triple negative. I was like triple negative, what is that? I didn't know that 
there were different types of breast cancer. I just thought breast cancer was breast 
cancer. (Topaz, p. 2)  
They were equally unaware of the progression of the disease and its aggressive nature. 
“He explained to me that stage one is the lowest but with the type of cancer I had it was 
very aggressive and fast growing so they had to treat it quickly” (Topaz, p. 2). To 
compensate for their lack of awareness, the women learned about TNBC from their 
physicians, as well as, engaging in their own research on the Internet. There was a mix of 
opinions about the level of specificity and the amount of information they received from 
their physician s regarding the aggressive nature of TNBC. This ranged from in depth 
detail to very little. “He was great because he even like drew a diagram and just showed 
me everything about the breast and the tumor. He was really, really good” (Topaz, p. 11). 
“I don't believe that even when I was diagnosed with triple negative this time, that I was 
made aware enough that this is somewhat of a really different kind of cancer. I was just 
told triple negative and that was from my oncologist” (Ruby, p. 20).  
 However, even when the physician explained the disease, and in some cases used 
visual aids, a full understanding of the disease did not take place during the physician’s 
consultation. In some cases, the name itself, TNBC, led to confusion. “I found out 
through my research that the triple negative, it was worse than what I understood it to be. 
You know, going in, the triple negative that sounds good. Okay, it would be even better 
to take care of because it’s negative” (Diamond’s daughter, p. 13). Women needed time 
to go home, process the information, and do some research of their own. 
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 Once the diagnosis was understood, the gravity of this form of breast cancer, as it 
is explained in the literature, may still not have been fully appreciated.  
So he said he would like me to see the oncologist because she might think I have 
to get chemo. So he had two names for me - the radiologist and the oncologist. So 
I went to her, the oncologist first. And she couldn't convince me why I needed to 
do chemo. And I was asking her all kinds of questions. I said for this little thing? 
(Citrine, p. 3) 
Yet, the aggressive nature of TNBC was realized when the diagnosis was not 
made early enough.  
[In] October everything was fine. When I went back in April, the cancer had 
broke through and grown like a weed. And like he said, if I had to wait till a 
couple more months for an ultrasound, or whatever, or mammogram, it would 
have been too late. That's how fast it grew. (Emerald, p. 2) 
The fact that the women did not have a full understanding of the disease, may 
have worked in their favor because the women did not view this as a devastating 
diagnosis. “Because even the radiologist didn't say, oh you have this and have to get that, 
and it was nothing that nobody made a fuss about” (Citrine, p. 4). Had they fully grasped 
the gravity of the situation, they may have experienced an added level of stress that could 
have altered their attitudes and behaviors throughout their journey. A full understanding 
of the devastating effects of TNBC could have diminished their sense of autonomy and/or 
ability to make their own decisions. 
 As Turkman described in her dissertation of exploring the psychosocial needs of 
African American women with TNBC, found that “women perceived their TNBC 
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experience as separate and different from the more common subtypes of breast cancer,” 
and “this knowledge, particularly the lack of treatment options, profoundly affected their 
sense of security and confidence in their future” (2014, p. 39 ). So, the question remains 
as to how much information physicians should give each woman about her breast cancer. 
Future discussion remains for determining what the appropriate amount of information to 
give is, and when is the appropriate time to give it.   
I think it's that thing where they don't want to scare the patient and, again, you can 
go online and in that case it's at your pace. You decide if you want to keep 
reading and scare yourself, or whether you're not going to be scared, but you're 
going to use the information. (Ruby, p. 20) 
SDOH: social conditions do not matter. Contemporary literature, as outlined in 
Chapter 2, leads us to believe that social conditions such as lack of insurance, access to 
information or physicians, and knowledge of screening guidelines are barriers to 
screening for women in urban environments. However, these were not identified as 
obstacles for any of the women in this study. The essential question for this study was to 
determine if women faced any barriers to their care due to SES or race. When asked 
specifically about race being a factor, the women struggled to identify a situation where 
they felt their race played a role. Ruby recounted an incident she had with her oncologist 
who refused to send her for a blood test. “If you ask me if I think race ever played a part 
in any of my whole journey, that would be the only time that maybe, but it's such a big 
maybe, I don't even know because it's a bizarre occurrence and I can't explain why he did 
that,” (p. 20). Overall, the women said that they did not feel as though race was a factor. 
“I didn't feel it. Oh no, maybe there is some bias somewhere, but I am not aware of it. I 
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didn't feel it” (Diamond’s daughter, p. 17); “I didn't get that feeling either” (Diamond, p. 
17). The overwhelming response was that they did not perceive any factors of SDOH to 
be barriers during their breast cancer experience; however, they could see how it would 
be an issue for others. “My answers are all no [regarding the SDOH factors]. But, I could 
see, it's quite obvious, that these are factors for other people” (Amethyst, p. 34). Age, 
language, and income were not cited as barriers, nor were they points of discussion 
during the interviews. 
Health insurance. Health insurance did not reveal itself to be a barrier. Five of 
the women reported that they had good health insurance and paid a minimal amount, if 
anything, for services.  
[I had] fantastic health insurance and I never worried once. Yeah, I felt really 
fortunate for that. I don't think even for the surgery I did [pay]. I kept waiting for 
chemotherapy co-pay bills to show up, but no, I did not pay co-pays for chemo. I 
don't think I paid a co-pay for the surgery. I had two surgeries and, yeah, it was all 
covered. (Ruby, p. 9) 
One of the five women even stated that she had such good health insurance, she 
received reimbursements for going to her appointments. “[Insurance] is wonderful I tell 
you. They would give me money for going to my treatments, chemo, radiation, they 
would send me checks. I'm like, oh my gosh, this is a wonderful policy” (Topaz, p. 12). 
While the sixth woman did share concerns about medical expenses because she had a 
high deductible insurance plan, she had made a deliberate decision to pursue alternative 
therapies which she knew would not be covered by insurance. “Insurance will cover a 
prescription, they won't cover herbs” (Amethyst, p. 27). Although Amethyst felt 
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insurance should cover her alternative therapy, insurance was not a barrier to her care as 
she consciously decided to forego conventional medicine in favor of natural remedies.  
If insurance covered it, it would be great. . . . [my supplements] have to be 
between seven, probably somewhere around $700 a month. That's still way 
cheaper. Let's say I could do that for a whole year, it's still way cheaper than a 
chemotherapy session which could cost $25,000 on average. (Amethyst, p.28)  
Access. Access to information also did not emerge as a barrier for these women. 
All of the women discussed having access to information and the ability to do research 
about their diagnosis.  
I read the papers they gave me because I'm just that way inclined. I was that kind 
of informed patient. I was also consulting Dr. Google, that's what my physician 
calls him. I was supplementing the information they gave me with information 
there and then getting questions from there that I could ask them. (Ruby, p. 8)  
As conventional research dictates, access to the Internet or information is usually 
cited as a barrier to care in communities with high concentrations of poverty. However, 
that was not the case for these women. “I would go on the Internet a lot after I was 
diagnosed. I would really try to educate myself more about the triple negative” (Topaz, p. 
20). And research was not just for the diagnosis; they were determined to understand as 
much as possible about their situation. “Afterwards, we did research. Why we have 
cancer? What was going on? And chemo, anything. All this was new to me” (Diamond, 
p. 3). One of the women, because she was adamant about not doing chemotherapy, also 
researched alternative treatments. “I started researching herbs and alternative methods. I 
added Qigong and I did additional research and found out there were specific yoga 
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interventions that had been studied and peer reviewed” (Amethyst, p. 5). They felt 
confident in their ability to read and comprehend the information they received from the 
Internet. “I'm fortunate that I know how to research and read and be an advocate for 
myself” (Amethyst, p. 11) 
While research states that screening guidelines, insurance status and access to 
information are factors in women’s health options and choices, this population of women 
did not have that experience. Remarkably, unexpected themes emerged that are a cause 
for discussion. Women shared similar feelings about the physician / patient relationship, 
importance of having a positive attitude, and perceptions of support groups. Each of these 
areas is explored in further detail below. 
The strength of a woman. Although SDOH proved itself not to be explanatory 
for these women, one theme emerged as a topic for discussion in all interviews. This 
overarching theme is captured as “strength of a woman” and revealed itself in the way 
these women chose to handle their diagnosis. The image of Black women as being strong 
and resilient in the face of adversity has been a hallmark of the literature for years 
(Shorter-Gooden, 2004). In her work on the resistance strategies of African American 
women coping with racism and sexism, Shorter-Gooden described three internal ways in 
which Black women deal with these life stressors: (a) standing on the shoulders of their 
ancestors and those who paved the way, (b) valuing themselves and maintaining a 
positive self-image, and (c) relying on their faith and spiritual beliefs (2004). Some of 
these strategies were displayed through the women’s stories in how they dealt with the 
stressor of having TNBC. “I stood on a lot of women’s shoulders. A lot of them” 
(Emerald, p. 30). 
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The women’s strength was evident in their convictions, their faith, and their will 
to survive this disease. This diagnosis was just something that happened in their lives; it 
was not something that was defining their lives. “So I'm very strong. Sometimes I think 
I'm too strong for my own good sometimes, you know? And I think that helped me, too” 
(Emerald, p. 8). They were clear and definitive about what they would do, what they 
would not do, and what they had to do. And, once they made those decisions, they were 
resolute. “You have to have your wits about you and do your research, and ask questions, 
and read up, and make the right appointments. Just tackle it, that's the next thing to do” 
(Ruby, p. 6). Strength showed itself repeatedly in how they managed their care and coped 
with the effects of this devastating disease. “Just the way that I handled it, I was much 
stronger than I anticipated. I was very strong” (Topaz, p. 5).  What’s humbling is that 
these women were not consciously being strong, they just were. “When people tell me 
that you're so strong and I'm, my first response is, huh? Really? I'm just living my life” 
(Amethyst, p. 11). The strength of a woman emerged with two subthemes, just as 
highlighted in the literature: faith and attitude. 
Attitude. In order to get through this diagnosis, it was clear that their positive 
demeanor and outlook on their situation was pivotal to the success of their treatments. 
“You know, I took a positive outlook on everything. I said, "That too shall pass." That is 
what I used to keep saying, "That too shall pass" (Diamond, p. 10). All of the participants 
shared that keeping a positive attitude through this experience is what kept them going.  
I just kind of wish that they . . . if they had to go through cancer, they would go 
through the way I went through. They said “Miss, I can't believe you going 
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through cancer, you supposed to be sad. Why I’m supposed to be sad? Why am I 
supposed to be sad, though? (Emerald, p. 30)   
It was obvious that having a good attitude meant that they looked good and felt good 
about themselves. “I didn't act sick, or didn't look sick” (Citrine, p. 5). In some cases, this 
was to the extent that people did not believe they were dealing with cancer. “They're 
looking at me like. ‘but you look so good!’. Like I was a faker, you know” (Amethyst, p. 
17). 
 However, the strength to stay positive through a negative time must come from 
somewhere. And, while they drew strength from various sources, their knowledgeable, 
their families, or their networks, they all had one thing in common, their faith.  
My faith was so strong that telling me that word wasn't a death sentence for me. I 
said ‘Lord, why not me? If everybody else could have something, why not me? 
But I know you are the healer and I have the faith in you. So I know you are 
gonna take care of me.’ And I went about my business. (Citrine, p. 2)  
 Faith. The power of faith was consoling and comforting for the women. “My 
faith is heavy, heavy, heavy. It's heavy. And I knew all the time that God is not in 
buildings. He's everywhere at the same time. He’s omnipotent with all power. It ain't over 
till He says it's over” (Emerald, p. 14). It brought them out of despair. “I got so low one 
time that I actually feel like I heard God talk to me. It really jarred me out of that depth of 
despair because it's not up to you” (Ruby, p. 13). And, it allowed them to continue to live 
their lives and follow their regular routines. “Well, first they'd be surprised that I'm still 
working” (Amethyst, p. 17). They never let the diagnosis hold them back or keep them 
down.  
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I just kept taking it one day at a time and doing what I could on those days that I 
felt good. I never did let it get to me. I never was mad or angry. I said well maybe 
this is something that's going to help me learn more about myself, and it did. 
(Topaz, p. 5)  
They talked about the ability to continue with their daily activities: mowing the lawn, 
going on vacation, cooking and going to church.  
But me and my God and you know, he takes care of me. And he really took care 
of me. Because I was cutting my grass, and I see my yard is long and all, I cut 
grass. I do all my stuff myself. (Citrine, p. 10)  
 The extension of the church and church family was just as critical.  
I have a very strong faith and my church was very supportive too. Very 
supportive. That's probably why I just reacted the way I did because of my faith 
through this whole thing when I was diagnosed the first time and the second time. 
(Topaz, p. 18) 
The power of prayer from the congregation was a source of strength and healing.  
I found a church near me and started attending and actually asked all these new 
people that I didn't know for prayer. It was a good experience because they 
welcomed me and so that saw me through the tail end of my chemotherapy. 
(Ruby, p. 13) 
“Soon as I got diagnosed I asked my church to put me on the prayer list” (Amethyst, p. 
16). And, prayer doesn’t only have to come from the church. “I cried, and then I called 
my primary care and he told me to come right away to his office. …he even prayed with 
me at the end of that visit” (Diamond, p. 2). 
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The strength that these women drew from their attitudes and faith is aligned with 
the literature which discusses strategies for how African American women deal with 
life’s stressors. Faith is an internal resource that research has shown helps African 
American women overcome trials and tribulations (Shorter-Gooden, 2014). 
The Physician / Patient Relationship 
A breast cancer diagnosis may be one of the most difficult health issues a woman 
may have to deal with in her life. It not only affects her, but her family, friends, 
colleagues and many others around her. As the woman is processing the diagnosis and 
the toll that the cancer will have on her life, her body, and her appearance, one thing she 
does not want to be concerned about is her health care team. “They were all very nice. 
They treated me with respect. The doctor would listen to hear what I had to say. … They 
were very concerned, I must say” (Diamond, p. 7).  
Research has shown that the significance of the physician / patient relationship is 
critical to optimal patient health (Peabody, 2014). The importance of these relationships 
was evident with the women in this study. “The doctors were always there for me, they 
answered all my questions, they gave me the literature” (Topaz, p. 11). All of the women 
expressed confidence and resolve in their ability to choose their physician, get other 
opinions, or change physicians, if necessary. “I was able to choose new doctors as I saw 
fit” (Ruby, p. 5). They were empowered to seek multiple opinions about their diagnosis. 
“I had an appointment for my third opinion because, in the meantime, I had lost faith in 
the one [doctor] I had chosen” (Amethyst, p. 9). 
This form of empowerment is of particular importance because women going 
through a breast cancer diagnosis interface with a number of physicians including: the 
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primary care physician (PCP) who may have provided guidance and referrals to the 
cancer specialist; the radiologist who identified the cancer through screening; the surgical 
oncologist or breast surgeon who removed the tumor; the medical oncologist who 
monitored and  managed their overall care and may have administered chemotherapy; the 
radiation oncologist who administered the radiation treatments; and the plastic surgeon 
who may have reconstructed their breast. With each physician, the women had to develop 
a new relationship and this could be a source of stress as they have to navigate this 
system.  
I'll always say this, that it's a very incomprehensive way basically everything just 
seems kind of fractured and broken up when you need to do more than one kind 
of treatment. For the surgery, it's a whole separate thing where you're trying to 
find the surgeons and talk to people and organize that. Then if you need 
chemotherapy it just doesn't bleed into the next thing really. It's now a whole 
other thing where you have to now find your oncologist. (Ruby, p. 6) 
However, once they do navigate the system, women want to have a care team that 
they can trust and rely on during this vulnerable time, “Because as I say, I thank God for 
the doctors I have. It was caught in time, and as I say, thank my radiologist for the time 
she took, and she really set up a program with me” (Citrine, p. 9). 
In general, the women discussed the good relationships they had with their 
primary care physicians (PCP) and the level of care they received from their health 
teams. “I can't say enough about them. I had really good doctors” (Topaz, p. 11). For the 
most part, the women enjoyed a trusting relationship with their primary care physicians. 
“I had trust in my doctors . . . I know I had a good doctor. And I knew he was gonna do 
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the right thing for me” (Emerald, p. 22). They also shared that these relationships played 
a significant role in helping them manage this process. “I'm fortunate, I'm super fortunate 
that my primary care doctor actually came around. That made a huge difference in my . . . 
my mindset” (Amethyst, p. 11).  
 However, at some point, with each of the women, there was a physician / patient 
relationship that did not go, as well. “He just refused. It was such an unusual way. This 
doctor was just a terrible, terrible person” (Ruby, p. 15). They each reported at least one 
negative experience with a physician who was dismissive or did not listen to their 
concerns about side effects of treatment, and this tended to be with one of the cancer 
specialists. “A lot of things that I was telling them, they were saying no that's not 
common. That's not one of the side effects” (Topaz, p. 4). Or, in some cases, made them 
feel as though they were delusional. “And I said, you know, I'm burning my nipple on the 
opposite side. Oh, that's in your mind" (Emerald, p. 11). At other times, they simply did 
not believe the physician even heard them.  
So they weren't really hearing me. No matter what I was saying, their ultimate 
goal was to get me to understand that they were here to kill the tumor, irrespective 
of whatever impact that had on my body and my psyche. (Amethyst, 6) 
Yet, the inner strength of these women did not allow them to sit silently and be 
dismissed or invalidated. At some point during the journey, each woman talked about the 
fact that they had to take a stand and advocate for themselves. 
Self-advocacy  
As defined by Molina et al. (2015), advocacy is the “ability to seek, evaluate, and 
use information to promote one’s health.” “I found that I was really having to advocate 
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for myself” (Ruby, p. 21). The power to advocate for themselves allowed them to speak 
up and refuse treatments in times of discomfort, “I told my oncologist that I'm going to be 
stopping the chemo treatment. They tried to persuade me but I was set in my way as I am, 
and I told her no” (Diamond, p. 2); uncertainty, “I'm saying no because I'm not going to 
take the medication unless I'm certain that it is estrogen positive” (Ruby, p. 14); fatigue, 
“I don't want another surgery. I said oh my gosh, I just can't go through that right now. I 
said I really cannot” (Topaz, p. 14); or lack of trust, “I lost faith because she, after seeing 
me multiple times, having access to my chart and literally looking at my boobs, she 
wasn't sure where to. . . her actions indicated to me that there may be some confusion 
about which areas were cancer and which areas weren't” (Amethyst, p. 9). 
These women were not passive about their health.  
I do remember specifically advocating for myself, asking questions, trying to 
bring the doctor's mind back to something he said two visits ago that somehow 
has fallen by the wayside, and watching him say, ‘Oh, yeah, I said that, didn't I?’ 
Me wondering oh my God, what if I didn't remind you? (Ruby, p. 20) 
 Furthermore, their actions were significant because research has shown that while 
patients may want to engage in collaborative relationships with their care team, they are 
reluctant to do so because they do not feel confident or adequately equipped to do so. Yet 
these women not only engaged, they had the wherewithal to make their own decisions 
about their health.  
Support  
Through their journey, the women talked about the support they received from 
family, friends, church, and coworkers. Having support, whether they used it or not, was 
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reassuring to them. Hence the surprise at finding out that most women did not go to a 
support group. And, in fact, had a negative perception of them. “You see, some of them 
support groups make you sicker than anything. You go there and you hear the stuff, and 
you're like oh my God” (Citrine, p. 9). 
Support groups. Prior to beginning this study, it was anticipated that cancer 
support organizations would be the primary source for participant recruitment. A large 
breast cancer organization, with a database of over 4,500 survivors, was contacted in 
order to identify potential participants. Surprisingly, this organization only yielded one-
third of the participant pool. Although the women in this study all confessed to receiving 
information about cancer support organizations either from their physicians or by finding 
it during their own research, most admitted to never pursuing the information any further. 
“I have never been to any. I was just going through my own stuff. That was enough. I got 
support [from my family], that I must say” (Diamond, p. 9). What was unknown to me 
was the perception that some women had toward these organizations. Of the women in 
the study, two-thirds of them believed that attending a support group would worsen their 
experience, dampen their spirits, or extract too much of their energy.   
In Rochester, there are two primary support groups for women with breast cancer, 
one which has a majority White population (80%), and the other specifically for African 
American women. These groups provide opportunities for peer mentoring, presentations 
and workshops facilitated by experts in the field, exercise classes, cooking information 
and recipes, meditation, and yoga programs, outings/parties, and book clubs, with support 
groups being a small part of what also happens there.  
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We don't talk about cancer all the time. We talk about food; we might talk about 
clothes. We might talk about kids; we might talk about husband; we might talk 
about family. But it's the outreach to us, you know, everybody's on the same 
journey. (Emerald, p. 18) 
Yet the perception of these organizations was mixed with women questioning the 
importance and relevance of these groups. Half of the participants never made any 
contact with these organizations because they believed that people who were involved 
with these organizations would have negative energy that would corrupt their positive 
feelings about their experience. 
It probably would've been depressing and people would probably be complaining, 
not complaining but angry or something then I would've had the attitude, ‘You 
know what? It's not worth being angry. Take one day at a time, life goes on.’ 
They might not want to hear me say that but I was over all this. I'm over that. I'm 
not angry so my whole personality is not like that. I don't even want to entertain 
that and I don't want you to say you should be angry. No I'm not angry. I'm not 
angry. (Topaz, p. 18) 
Conversely, one participant did attend both organizations. At one organization she 
took advantage of the learning seminars but shied away from the support group. At the 
other, she attended the support group and was disappointed and uncomfortable with the 
experience.  
They did something that wasn't comfortable for me when everybody went around 
introducing themselves. My name is. . .; I had this kind of cancer, and this was my 
intervention. When I went I still wasn't telling people that I even had cancer, let 
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alone all the details of it and what I wanted to do. So I wasn't comfortable with 
that. (Amethyst, p. 18) 
Of the two remaining women, each are members of one of the support 
organizations and they are both promoters for their organization. However, as they are 
both long-time survivors, they function as mentors and advocates for women, as opposed 
to individuals seeking support. This makes their perspective a little different because they 
are operating from a space of knowledge and wisdom with the ability to offer support to 
women who need it. “You really do have to mentor women not to just be the sick, poor 
person because, unfortunately, they miss things and it's too rushed. You have to advocate 
for yourself. I cannot stress that enough” (Ruby, p. 21). 
This paradox about support groups was a surprising discovery in this study. 
Subsequently, I attended a meeting at one of the organizations and the executive director 
was aware of the negative perception and many attendees shared those beliefs. One 
attendee stated that she didn’t want to attend a support group because she associates them 
with alcoholics and drug addicts. Hence, they have changed the name from support 
groups to networking groups. The executive director also commented that she knows that 
strong women are not looking for support; they are looking for information, comradery 
and distractions from the current situation. This could explain the difficulty in recruiting 
many participants through this channel. 
Summary of Results 
The aim of this study was twofold: first, to understand the lived experience of 
African American female survivors of triple negative breast cancer (TNBC), and second, 
to determine if any of the key tenets of the social determinants of health influenced their 
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screening through treatment decisions or care. Both aims were met. Through the 
interview process, the first aim was met and a full accounting of the women’s journeys 
were recorded and summarized for each research participant. The second aim was 
answered through the women’s accounts of their journey. They all stated unequivocally, 
that their screening through treatment options were not influenced by social conditions, 
but by relationships, research and/or prior experiences. The findings for the second aim 
are highlighted in the first theme, SDOH: Social conditions do not matter.  
The experiences of this group of women went against the contemporary literature 
on African American women with TNBC. These women covered the economic, 
educational, age, and geographic spectrum; yet, they had fairly similar experiences. 
SDOH was not part of their experience. None of the women felt that they experienced 
racism or substandard care because of their age, race, SES, or any other factor. In this 
study, the SDOH framework did not account for the protective factors of strength, 
resilience, and faith inherent in each woman that allowed them to mitigate the damage 
this disease could have caused to their psyche and overall well-being. 
These protective factors were revealed through the theme, strength of a woman. 
This theme encompassed sub-themes about faith and self-advocacy. Their depth of faith 
when dealing with adversity and the importance of the ability for self-advocacy was 
paramount for these women to successfully beat their diagnosis. Yet, the question 
remains, what would have been different if they were a different race, specifically White? 
Would the information given to each woman about TNBC have been deeper and more 
consistent across providers? Would their need to advocate and research have been as 
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great, or would more information have been provided to them in advance? These 
questions are discussed further in Chapter 5. 
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Chapter 5: Discussion 
Introduction 
The purpose of this study was to understand the lived experience of African 
American, female survivors of triple negative breast cancer (TNBC), and to determine if 
any of the key tenets of the social determinants of health, particularly race and 
place/social conditions, influenced their screening through treatment decisions or care. 
This study was conducted using an interpretive description approach of qualitative 
methodology which allowed the researcher to use an iterative process for collecting and 
analyzing data. Semi-structured interviews were conducted to capture the experiences of 
six women who live or work in one of eight target zip codes within the city of Rochester.  
The first aim of the study was to understand the lived experience of African 
American female survivors of TNBC. This aim was met through the interview process. A 
full accounting of the women’s journeys was recorded and summarized for each research 
participant in Chapter 4. The second aim was to determine if any of the key tenets of the 
social determinants of health (race, educational level, age, income status, health insurance 
status, socio-economic status or language) influenced their screening through treatment 
decisions or care. This was answered through the analysis of the women’s accounts of 
their journey and their completion of the SDOH factor checklist. All women stated that 
their screening through treatment options were not influenced by race or social 
conditions. Personal factors and relationships emerged as the key influencers for their 
decision making.  
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Discussion of Findings 
Six amazing women were interviewed for this study. Other than the fact that they 
were all African American women, this was a demographically diverse group of 
survivors. Their ages ranged from 43-75 years old. Their incomes ranged from less than 
$20K to more than $100K, their marital statuses covered all categories of married, 
separated, divorced, and widowed, and they all lived in different sections of the city. In 
addition to being demographically diverse, their demeanors differed from mild-mannered 
and easygoing, to assertive and straightforward. Cultural backgrounds and family 
upbringing also varied as the women had Caribbean, southern or northern heritage.  
Finally, there were no observable, physical limitations that the women were 
challenged by.  They did not appear to be overly obese or overweight, did not use any 
walking aids, and seemed to be in general good health. In fact, a few of the women 
discussed the importance of being healthy and exercising. “I guess that people exercise, 
healthy living, that is so important. I cannot stress how important, especially if you're 
overweight, you have got to do something. You have to. You have to,” (Topaz, p. 21). 
And, while many of them did not know each other, they shared a common experience in 
their triple negative breast cancer journey.  
As outlined in Chapter 2, a plethora of quantitative research cited SDOH as a 
significant, contributing factor to poor health for people living and working in high 
poverty communities. Quantitative research has demonstrated that women who live or 
work in lower socioeconomic communities could experience barriers that inhibit their 
access to quality, affordable health care which could lead to higher mortality rates. The 
prevailing research question of this study was to determine if the experiences of women 
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living in communities described by the SDOH would mirror the results reported in the 
quantitative research. Would these women encounter barriers to screening due to 
confusing screening guidelines (Amirikia et al. 2009), or face challenges that would 
prevent them from getting timely follow up care from health care providers? Would they 
encounter inadequately staffed facilities, or would treatment be cost prohibitive because 
of lack of insurance (Adams et al., 2012)? Furthermore, would they be met with 
interpersonal or structural racism that would impede their care, (Jones, 2000)? The 
answer to this question was a unanimous and resounding, “no.” “My answers are all no 
[regarding the SDOH factor list]. But, I could see, it's quite obvious, that these are factors 
for other people,” (Amethyst, p. 34). The findings of this research study did not support 
that claim. 
SDOH, as it related to the African American women in this study, did not appear 
to be a relevant issue. These six women, who represented a diverse group of women, 
experienced TNBC in similar ways. Regardless of income level, marital status, 
educational background or area in which they lived, they all had access to resources, 
credible knowledge about screening behaviors, the ability to access and receive care for 
their screenings, diagnosis and treatments, and the wherewithal to advocate for 
themselves. 
This is a surprising finding because as conventional discussions of SDOH in 
Rochester suggest, the women would have encountered some barriers based on where 
they lived (FLHSA, 2014). This raises the question of whether or not the women in this 
study were a true representation of the women in those communities. If they were not, 
then future research should be done to recruit a more representative group of women. If 
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they were, these findings bode well for the level of breast cancer prevention and early 
detection education in Monroe County, which has long been recognized for its higher 
than average breast cancer screening rates for African American women (Monroe County 
DOH, 2012).  
This could also speak to the level of awareness raised by New York State which 
has made the early detection of breast cancer through screenings a priority. NYS leads 
the nation in ensuring women, regardless of insurance status, have full access to breast 
cancer screenings at convenient times with no cost to them (NYS Senate Bill S8093, 
2016). NYS is the only state that requires insurance companies to cover breast screening 
and diagnostic imaging for women without cost-sharing (NYS Senate Bill S8093, 2016).  
This expansion of health care insurance goes beyond the provisions of the 
Affordable Care Act which guarantees no cost for preventive screening, but not 
diagnostic imaging (H.R.3590 - Patient Protection and Affordable Care Act, 2010). New 
York State also launched a 5-year campaign to increase breast cancer screening rates by 
10% by 2021 (governor.ny.gov, 2016). Part of this campaign takes direct aim at 
providing access to technology that will disproportionately benefit women of color, 
providing more access to screening that will assist women in high poverty communities 
where facilities are not easily accessible, and implementing legislation that will provide 
funding to low-income women with financial barriers to screening (New York State 
Governor Andrew M. Cuomo, 2016).  
 However, it should not be concluded that health outcomes would be equivalent 
for other forms of cancer, or other chronic diseases, for that matter. As outlined in 
Chapter 1, the report of the African American Health Coalition revealed the devastating 
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health condition of people who live in the eight Monroe County zip codes with the 
highest concentration of poverty. African Americans in these zip codes suffer from 
multiple, preventable chronic diseases and have a 300% higher premature death rate than 
their White counterparts (FLHSA, 2014). 
 Furthermore, issues of racism in Rochester have been highlighted through the 
work of the Rochester Monroe Anti-Poverty Initiative (RMAPI, 2015).  While 
individuals may not personally feel overt racism, examples of structural and institutional 
racism exist throughout health care and are a cause of health disparities and inequities 
(Smedley, 2002). Yet, it is common for people to not recognize racist acts perpetrated 
against themselves, but yet to perceive that it happens to others (Rojas-Sosa, 2016).  
The women in this study were hard-pressed to identify instances of racism. Ruby 
recounted the incident she had with an oncologist who refused to send her for a blood 
test. “If you ask me if I think race ever played a part in any of my whole journey, that 
would be the only time that maybe, but it's such a big maybe, I don't even know because 
it's a bizarre occurrence and I can't explain why he did that,” (p. 20). Yet, Jones (2000) 
contends that even with advances in socioeconomic status and access to care the 
destructive nature of racism and discrimination is ever present. 
Strength. African American women are known for their strength and resilience 
(Shorter-Gooden, 2004). The image of strength in the face of adversity has become a 
sense of pride and badge of honor in African American communities. However, due to 
the health conditions of the Black community (FLHSA, 2014), it is obvious that Black 
women must do more to take care of themselves and their health. Her strength may 
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sometimes be a hindrance to her good health as she may erroneously believe that she can 
handle more than she actually can.  
As stated by many of the women, they chose to go through their journey alone 
without leaning on others (Amethyst, p. 7; Emerald, p. 8; Citrine, p. 5). This speaks to 
their innate strength that is discussed in the literature. However, they also shared the 
welcomed comfort and support they received from family and friends when they were not 
expecting it. Being the caregiver is what many Black women are known to be and have 
always been. For centuries, they have cared for others, then their own, and lastly, if at all, 
themselves. These women should not have to also shoulder the burden of cancer on their 
own. Black women must learn to accept and rely on the support and strength of others, be 
that from family, church, or women who have had the same experience. This may be 
found in support groups, as well.  
Information. As discovered in the interviews, the need for information was great. 
All of the women reported conducting supplemental research to fill the gaps in 
information received from their provider. They needed to understand their cancer, and get 
as much information as possible. However, it is common that providers tend to 
underestimate how much information their patients need, when they need it, and in what 
format (Ong et al., 1995).  Ong et al. reported that while doctors believe they are giving 
precise, thorough information, the patient’s needs are not met because they are not 
receiving the type of information that is relevant to them. Hence, the women all sought 
out information on their own throughout the process. 
This could be interpreted as the women not getting as much information as they 
needed, or that they wanted a secondary source of information to confirm what they were 
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hearing from the provider. As noted by Ruby, “unfortunately, they [doctors] miss things, 
and it's too rushed. The system is too rushed. There's too much going on.” If this is the 
case, there are implications for how providers disseminate information to their patients.  
Self-advocacy. Self-advocacy emerged as a theme because at some point, with 
each of the women, they mention having a poor interaction with one of their cancer 
specialists. They encountered a situation where their physician did not listen to them, was 
dismissive of their concerns, or blatantly disregarded their request. It was at this time that 
they had to advocate for themselves to ensure they received the care and attention they 
wanted. However, as research has shown, self-advocacy is not common among cancer 
patients (Blumenthal-Barb, 2017).  
Blumenthal-Barb’s study has shown patients tend to defer to the physician for fear 
of being perceived as difficult. This phenomenon is contextualized through culture and 
values stating that in studies of patience reluctance to be an active part of shared 
decision-making, the patients look to the physician as an authority figure and do not want 
to appear to be problematic. This occurs even in life-threatening or life altering situations 
when the patients should be active participants. However, even in life-threatening 
situations, patients tend to trust in their physician’s knowledge and experience and defer 
to their physician’s recommendations.  
Additionally the reluctance to challenge physicians is also seen in populations 
with lower education levels as well as people who are unfamiliar with medical 
terminology. In a focus group study of patients discussing cancer screenings, researchers 
found that those who are unfamiliar with words, such as tumor, tended not to ask as many 
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questions, (Blumenthal-Barb, 2017). This makes it difficult for the physicians to 
determine the level of understanding that these patients had.  
However the women in this study, regardless of education level, socioeconomic 
status, or cultural background all exercised their right and duty to be active participants in 
their care. They questioned their care team, challenged the physicians at times, and 
advocated for themselves when necessary. These women were not passive patients. They 
cared about themselves and their health, and insured that when their well-being was in 
question that they took responsibility to make sure they knew what was appropriate for 
them. 
Faith. Faith was another theme that emerged as an anchor for these women. As 
mentioned previously, they experienced their cancer diagnosis as an event that happened 
in their lives and not something that would determine their lives. They had a positive 
attitude throughout their journey. Topaz mentioned finding peace in her life through this 
diagnosis, Citrine talked about knowing that she would be OK because she believed in 
the Lord and he would see her through, and Amethyst talked about the power of prayer. 
These women leaned on their faith to get them through this difficult journey. As best said 
by Citrine, “my faith was so strong that telling me that word wasn't a death sentence for 
me.”  
Reliance on faith has been discussed in the literature (Lynn & Levine, 2014). In 
their study, Lynn and Levine examined African American women with breast cancer to 
understand how they coped with their diagnosis. They found that religious and spiritual 
practices were an integral part of the women’s coping strategies. The women in their 
study talked about the importance of attending religious services, being part of the church 
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community and having people pray for them, as well as the comfort they found through 
prayers and the encouragement through reading biblical scriptures. This study also 
showed that the faith that Black women have reflects in a better quality of life that they 
enjoy even when going through a serious diagnosis like breast cancer. 
Implications and Recommendations 
Bias toward African Americans has a long and distinct history in this country. 
There have been multiple studies that evinced the association between perceived racism 
and poor health outcomes. Taylor et al. (2007) found that women under age 50, who 
reported frequent everyday discrimination, were at higher risk for breast cancer than 
those who reported infrequent experiences. Other studies have identified systematic 
differences in how chemotherapy was administered to African American women 
compared to White women (Griggs et al., 2003). These studies are evidence of how bias 
plays a role in the disparate health outcomes of African Americans in this country. The 
findings from this study have implications for researchers, physician practices, and 
patients. 
Researchers. Quantitative researchers have identified areas of structural racism 
and implicit bias in their findings, as discussed above. Structural racism is embedded in 
the structures and policies that shape the lives of Americans. It also underscores the link 
between race and place as African Americans, disproportionately, tend to live in low 
socioeconomic environments. Conventional wisdom dictates that living in low SES 
environments increases the likelihood of poor health outcomes. However, quantitative 
research may not take into account protective factors such as faith, support, and inner 
strength that serve to mitigate challenging social factors. In this study, the women did not 
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succumb to the conditions of their environment or their disease because they relied 
heavily on their faith, inner strength, wisdom, and self-advocacy skills to help them fight 
against forces that could have impeded their care.  
Public health researchers focus on risk factors and may not consider protective 
factors that allow people to resist or overcome those risk factors. Researchers should 
consider using measures of protective factors in their studies that could give a fuller 
understanding of participants’ experiences. There are several tools that could be used to 
measure spirituality and resiliency when coping with diseases. This would allow for a 
holistic view of study participants and better predictors for health outcomes. 
Physician practice. Although the women in this study reported that racism did 
not play a role in their care, the larger societal and structural forces must not be 
overlooked. While physicians may not be aware of their biases, it is evident from the 
previously cited research that biases do exist and are present in patient care. Health care 
professionals should consider taking steps to become more aware of their implicit biases. 
There are various trainings available that discuss areas of cultural humility, implicit bias, 
and structural racism. Physicians could seek out and participate in cultural awareness 
training that speaks to the role that racism and implicit bias play in the health care field. 
Additional barriers could be placed if women feet that racism or bias was seeping into 
their care. Engaging in honest conversations about race and racism, and working to 
dismantle policies and symbols of racism and oppression in the health care field, could 
help with building trusting relationships with their patients.  
Ensuring good educational training is equally important because it was clear that 
the women wanted more information about their disease in a format they could 
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understand. Research has shown that while patients may want to engage in shared 
decision making with their care team, they are reluctant to do so because they may not 
feel confident or adequately equipped to participate in a collaborative discussion with 
their physician about their health needs (Frosch et al., 2012). Physicians must be 
inclusive of their patients thoughts and ideas to ensure shared decision making. 
Additionally, the women talked about the amount of information and resources 
they received from their physicians regarding their TNBC, and stated that it was not 
enough. They also reported there was no consistency with what information was given, 
when the information was given, and by whom. Hence, health care providers may 
consider creating a process that will aid in the smooth, concise, and comprehensive flow 
of information to their patients. Teams should consider: 
• who would be best to convey needed information to the patients (physicians, 
nurses, social workers, etc.), 
• at what point during treatment it would best be conveyed (consultation, 
follow-up, special appointment, or a combination of times),  
• what information should be conveyed based on the patients’ needs and wants, 
and, 
• in what format the information be conveyed (face-to-face, reputable resource 
list, brochures, and pamphlets, email/text messages, etc.). 
Making more information available to their patients, in a way that they will understand, 
will help patients feel equipped and knowledgeable to participate in shared decision 
making. Information should also be provided in a manner that is inclusive of different 
races and languages.  
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Additionally, the women all shared that they had good, trusting relationships with 
their PCPs. This may have been the first physician they talked to about their diagnosis, 
confided in, and trusted with their sensitive information. Unfortunately, other than giving 
a referral to a surgeon, the PCP is not typically involved in the patients’ cancer journey. 
That tends to fall under the purview of the cancer team of oncologists and surgeons. 
However, there may be a larger role that the PCP can play with their breast cancer 
patients.  
As the ACA forces health care providers to move toward a medical home model, 
it gives way for the PCPs to be more involved in their patients’ care as part of the cancer 
team. While the PCP is not an expert in cancer, nor is he/she expected to be, there is a 
critical role that they could play. The PCPs involvement would be more of a collaborative 
approach with the patient to: reinforce information received from the cancer team; ask 
questions to ensure the patient understands medical directions, assist the patient in 
reviewing instructions and formulating questions, and encourage the women to follow up 
on instructions received from their cancer team. PCPs could consider instituting a process 
of following up with each patient after their initial visit with their cancer team. The PCP 
would not be expected to be a cancer expert, but to be a trusted source, and sounding 
board for the patient during times of uncertainty.  
This would be a new role for the PCP as they are currently not involved after the 
cancer diagnosis. They may not receive reports of the patients progress through their 
treatment, or be kept abreast of any issues or concerns. Moreover, the PCP may not be 
incentivized to participate in this way, as there is no reimbursement mechanism for the 
PCP to bill for consultative or advisory services during the patients’ cancer treatment. 
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Yet, it is the PCP with whom each woman remembered having the positive, trusting 
relationship. Therefore, a new reimbursement structure may need to be developed to 
allow physicians to allocate time to their patients who are dealing with a cancer 
diagnosis.  
Patients. Research has revealed that African American women are strong, 
independent and resilient through the most trying times. However, this strength could 
also become an unintended barrier to their well-being. Women going through a diagnosis 
as serious as cancer should learn to accept help. Many of the women chose to go through 
their journey alone, even though they did not have to. Amethyst stated that she did not 
see the point in involving other people. However, in retrospect, she admitted that she 
should have taken someone with her to her first appointment. No matter how strong a 
person is, it can be helpful to have another person available to take notes, think of 
questions, and help advocate, if needed.  For the most part, that type of assistance will 
come from family or friends. However, there are times when it may come from strangers.  
Although support groups were not embraced by most of the women because they 
perceived them as being filled with negativity and depressing conversations, it is an 
alternative that breast cancer patients may want to consider. According to Emerald, 
support groups offer more than depressing conversations and angry outbursts. They offer 
advice, distractions from the present circumstance, referrals for better care, and laughter 
in place of grief. They also offer advocacy, unity, and purpose for those who want to do 
more to fight their disease. From Emerald’s and Ruby’s point of view, there is a lot of 
positivity and information that comes from support groups. Therefore, women with a 
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breast cancer diagnosis may want to allow themselves time to learn more about these 
groups. They may be surprised to find that they could tap into another source of strength.   
Limitations 
The contemporary, quantitative research shows that TNBC is more likely to occur 
in young women under the age of 40 years of age. However, the women identified for 
this study were all diagnosed with TNBC over age 40. The lack of recruiting women, 
ages 39 and younger, to this study could be viewed as a limitation. Life experiences, 
knowledge and circumstances may have differed for younger women in contrast to older, 
more established women. Young women may have endured additional challenges 
associated with attending or finishing college, experiencing their first brush of 
independence without parental constraints, establishing a career, starting or raising a 
family, or dreaming about what their future holds. As screening guidelines do not target 
women below the age of 40, a cancer diagnosis for someone just starting their adult life 
could be a devastating incident. Future research may warrant inclusion of this particular 
population as the likelihood of TNBC occurring in women of this age group is 
significantly higher. 
Additionally, this study aimed to discover if social conditions were a factor for 
women living in high poverty communities. However, the women in this study may not 
be representative of most women in those neighborhoods. The income level of most 
women in this study was not that of women in poverty. Although, the participants lived 
and/or worked within the eight zip codes area, five out of six of the women an income 
range that was at 350% or higher of the 2017 Federal Poverty Level set at $12,060. Yet 
the average income for an African American household in Rochester is $27,078. 
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As these women had higher than average incomes, they were not burdened with 
some inconveniences that lower income women may have encountered. For example, 
they all had reliable transportation that allowed them to easily access care. They all had 
personal computers in their homes and the ability to do research which allowed them to 
access information about their TNBC diagnosis freely. They all had health insurance so 
that finances did not pose a barrier to their care. Had they been of a lower SES, their 
ability to navigate barriers may have been impaired and given rise to challenges in 
screening through treatment options.  
Future Studies 
This research study helps to fill a gap in the literature that does not address the 
lived experience of Black women who live or work in low socioeconomic environments 
and have this aggressive form of breast cancer. Although the study participants reflected 
a diverse spectrum of income, marital status, educational level it was a small sample size 
was small and cannot be used to generalize for all African American women with TNBC. 
Yet, this study lays the foundation for future research in multiple areas.  
Since the participants were all of the same race, this study did not allow for a 
comparative analysis of experiences against women of other races. While it was beyond 
the scope of this study to compare the experience of African American women to that of 
White women, future studies may choose to include women of various races and 
ethnicities to determine if there are significant differences in the way women are treated 
by their physicians, the timeliness of appointments, the amount of information that is 
received, and the level of advocacy that is required to ensure proper care. 
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Additionally, per the NYS Vital Statistics (2013) the mortality rate of women 
dying from breast cancer in these zip codes was 55.9 compared to 49.5 per 100,000 for 
the rest of the county. Future research may include the families of women who lost their 
battle with TNBC. Insight from the family on how the decedent experienced their journey 
could give new understanding to this topic.  
Researchers may also want to study the feasibility of PCPs playing a new and 
extended role in the care of their patients with breast cancer. It would be essential to 
weigh the benefits and challenges of a new practice model for practitioners to understand 
how they could implement a new method of care for their breast cancer patients. 
Finally, researchers may want to expand upon this study by including African 
American women aged younger than 40, and those with lower income levels. According 
to the research, TNBC is more likely to found in younger women under age 40. In 
addition, women in lower SES may have more barriers to access for screenings and 
treatment. Ensuring a study population was inclusive of these two groups will further 
enhance the field of knowledge.  
Conclusion 
This was a qualitative study of six African American women who were diagnosed 
with TNBC and lived or worked in eight specific zip codes in the city of Rochester. 
Qualitative research is not meant to be generalizable but to describe the phenomenon of 
the lived experiences of the participants (Leung, 2015).  The findings from this study 
serve to complement the existing quantitative research. The detailed accounts of each 
woman add a depth of knowledge about how African American women experience 
TNBC that should not be ignored. As outlined in Chapter 2, qualitative research that 
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highlighted the lived experience of African American women with TNBC was 
nonexistent. Yet, this study gives a look into the lives of these women, that is often 
ignored in quantitative research.  
While SDOH is important for assessing risk factors, it does not tell the whole 
story. Although it is clear that issues of race and place matter, they were not barriers for 
any of the women in this study. Protective factors of strength, resilience and faith may 
mitigate social conditions and allow women to thrive even in the worst circumstances. 
This knowledge should be used to enhance the field and can be transferred to future 
research. 
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